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Abstract
Survival analysis is a branch of statistics to analyze the time-to-event data or survival
data. One important feature of survival data is censoring, which means that not
all the subjects’ survival time are observed directly. Among all the survival data,
right-censored data are the most common type and consist of some exactly observed
survival times and some right-censored observations. In this dissertation, we focus
on studying flexible regression models for complicated right-censored survival data
when the classical proportional hazards (PH) assumption is not satisfied. Flexible
semiparametric regression models can largely avoid misspecification of parametric
distributions and thus provide more modeling flexibility.
Cure models are studied in this dissertation to analyze survival data, for which
there is a cured group in the study population and this is evidenced by a level-off at
the end of the nonparametric survival estimate. In addition, we also incorporate back-
ground mortality in the cure models to improve estimation accuracy in this research.
Considering the background mortality is important based on the fact that patients
dying from other causes also benefit from the treatment of the disease of interest
as shown in the SEER cancer studies. In Chapter 2, a semiparametric estimation
approach is proposed based on EM algorithm under the mixture cure proportional
hazards model with background mortality (MCPH+BM). In Chapter 3, a promo-
tion time cure proportional hazards model with background mortality (PTPH+BM)
is proposed, and its extension to the semiparametric transformation model is under
further exploration. Both models are validated via comprehensive simulation studies
and real data analysis.
iv
Another perspective on non-proportional hazards is to explore a more general
model than the Cox PH model such as the generalized odds-rate (GOR) models
(Dabrowska and Doksum, 1988). In Chapter 4, the identifiability problems and the
estimation of parameters in the GOR models are discussed.
v
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Chapter 1
Introduction
1.1 Survival Data
Survival analysis is a collection of statistical procedures that study the duration of
time until one particular event of interest happens and thus it is also called time-
to-event analysis. The survival time can be years, months, weeks or days from the
beginning of follow-up of an individual until the event of interest occurs. The event
of interest can be death, disease incidence, relapse from remission or recovery from
disease that may happen to a patient. For example, if the event of interest is death,
then the survival time will be the time in years until a patient dies. However, the
survival time may not be observed directly in some cases. In some studies especially
in clinical trial studies, patients are examined only at discrete observational times,
and the statuses whether the patients have experienced the event of interest or not
at these observational times can be recorded. However, the event time may not be
known exactly but be known to fall within some time interval. In other studies,
some patients may not experience the event of interest by the end of a study, or
some patients have already experienced the event of interest before being recruited
in a study. All these phenomena are called censoring, where some survival time of
interest can not be known exactly.
Censoring occurs when we have some information about subjects’ survival time,
but we do not know what are their exact survival time. Thus censoring is a condition
in which a subject’s survival time is only partially known. For example, a patient
1
moves to another state after being recruited to a clinical trial and is lost to be traced.
The only information available on his or her survival time is the last date on which
this patient was known to be alive. This date may be the last time that this patient
reported to a clinic for a regular check-up.
There are various categories of censoring, such as right censoring, left censoring,
and interval censoring. Right censoring occurs when a subject’s exact survival time
is not observed and is known to be greater than this person’s observation time. Left
censoring occurs when a subject’s exact survival time is less than or equal to this
person’s observation time. Interval censoring means a subject’s exact survival is only
known to lie within an interval instead of being observed directly. Below are some
real life examples to illustrate different censored data.
1.1.1 Right-Censored Data
The Acute Leukemia Group (1963) has reported the results of a clinical trial of a drug
6-mercaptopurine (6-MP) versus a placebo in twenty-one pairs of patients with acute
leukemia. This trial was conducted at eleven American hospitals. Patients who had
a complete or partial remission of their leukemia induced by treatment with the drug
prednisone were selected. A complete or partial remission means that either most or
all signs of disease had disappeared from the bone marrow.
The trial was conducted by matching pairs of patients at a given hospital by
remission status (complete or partial) and randomizing within the pair to either a
6-MP or placebo maintenance therapy. Patients were followed until their leukemia
relapsed or until the end of the study. The event of interest is the relapse of leukemia
and the survival time is the time in weeks until patients went out of remission.
Part of the patients records are shown in table 1.1. Patient A was followed from
the start of the study until getting leukemia relapsed at week 5, so this person’s
survival time was observed to be 5 weeks. Patient B was observed from the start
2
Table 1.1: Partial patients records in acute leukemia data
Patient Enter Time End Time Reason Failed(1); censored (0)
A 0 5 out of remission 1
B 0 12 study ends 0
C 2.5 6 withdrawn 0
D 4 12 study ends 0
E 3 9 lost to follow up 0
F 8 11.5 out of remission 1
of the study, but did not experience the relapse until the end of the 12-week study
period, so this person’s survival time was censored and at least 12 weeks. Patient C
entered the study between week two and week three and was followed until he or she
withdrew at week 6, so this person’s survival time was censored. Patient E entered
the study at week 3 and was lost to follow at week 9, so this person’s survival time
was censored and at least 6 weeks. In summary, the patient A and F experienced
leukemia relapse and their survival times are known exactly. The other four patients
did not experience leukemia, and thus their survival times are right-censored. This
data set is an example of right-censored data in the survival literature, which contain
some exactly observed survival times and some right-censored survival times.
1.1.2 Left-Censoring Data
One example is that in early childhood learning centers, research interest often focuses
upon testing children to determine when a child learns to accomplish certain specified
tasks such as reciting the alphabet. The age at which a child can recite the alphabet
would be considered as the time-to-event. Often, some children are already able to
recite the alphabet when they are recruited in the study. Such survival times are
considered left-censored.
Another example is on clinical trial studies. Human immunodeficiency virus (HIV)
is a chronic disease which weakens the immune system. HIV RNA or viral load
(VL) measures the number of actively replicating HIV virus in a subject, which is
an important biomarker for HIV disease. The suppression of VL to undetectable
3
levels can improve physical functioning and reduce HIV related mortality. VL is
undetectable if it has less than 200 copies of HIV per milliliter of blood by the CDC
guideline. In a study of the HIV, the observations start from the time points when
patients’ VL reach detectable levels. However, the exact survival time that some
subjects’ VL reach detectable levels are unknown and these survival times are left-
censored.
1.1.3 Interval-Censored Data
De Gruttola and Lagakos (1989) discussed the study involving a cohort of hemophil-
iacs for whom both infection with the HIV and the onset of the acquired immunode-
ficiency syndrome (AIDS) or other clinical symptoms. The data were collected from
262 patients with type A or B hemophilia in France between 1978 and 1988. Twenty-
five of the patients were detected to be infected with HIV on their first lab tests. By
August 1988, 197 hemophiliacs had been infected and 43 of these showed the acqui-
sition of AIDS or other clinical symptoms such as lymphadenopathy or leukopenia.
These patients were believed to become infected from the infusions of contaminated
blood factor they received periodically to treat their hemophilia. Blood were pe-
riodically sampled and stored to decide a time interval during which the infections
occurred. Thus, the infection times were censored within a time interval with changed
status from negative to positive.
1.2 Motivating Data
Right-censored data are the most common type of censored data in oncology studies
and cancer statistics. In these studies, the time-to-event is usually the survival time
until death. In this dissertation, we focus on analyzing right-censored data in different
survival models. The data for illustration are from the Surveillance, Epidemiology,
and End Results Program (SEER) (Howlader et al., 2019). The SEER cancer data
4
is the research data from population-based cancer registries covering approximately
34.6 % of the United States population. The SEER registries collect data on patient
demographics, primary tumor site, tumor morphology, stage at diagnosis, and first
course of treatment, and they follow up with patients for vital status. The vital status
is recorded as dead or alive.
Breast Cancer Data
Breast cancer is fairly common in female, representing about 15.2% of all new cancer
cases in the United States. Female breast cancer is the fourth leading cause of death
in the United States, and it is most frequently diagnosed among women aged 55-64.
Women who are diagnosed at older age may be more likely than younger women to
die of the disease, and family history increases the risk of breast cancer (Howlader et
al., 2019). Regional breast cancer, which is defined as cancer cells spread to regional
lymph nodes, accounts for 30% of all the cases by stage. The 5-year relative survival
probability for regional breast cancer is 85.5%. For illustration, we use the SEER
Louisiana regional female breast cancer for patients of age > 50 with the diagnosis
year between 2000 to 2012 (Howlader et al., 2019).
A total of 6200 patients were included in this study with a mean age at diagnosis
of 65.7 years old, a censoring rate of 59.5% and a maximum follow-up time of 12.9
years. 1933 patients (31.2%) were older than 70 years old, 4236 patients (68.3%) are
white, and 1964 patients (31.7%) are black. There are also other races in this data
set, but we focus on the comparison between the white people and the black people.
Figure 1.1 shows that there is a significant difference in survival probability be-
tween the white and the black with the log-rank test p-value= 6e-08. We further
illustrate the Kaplan Meier curve stratified by each race and age (> 70 and ≤ 70)
group in Figure 1.2, which indicates the survival probabilities also vary by age groups.
The four subgroups including white and age > 70, black and age > 70, white and
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Figure 1.1: Kaplan Meier curve by race: the dark black line represents the survival
probability for the black people and the light grey line is the overall survival proba-
bility for the white people.
Figure 1.2: Stratified Kaplan Meier curve by Age 70: from light grey to dark black
successively are the overall survival probabilities for white of age ≤ 70, white of age
> 70, black of age ≤ 70 and black of age > 70.
age ≤ 70 and black and age ≤ 70 have significant different survival probabilities (p-
value=2e-16). It is worthwhile pointing out that in this data set, the event of interest
is the record of vital status of either being dead or alive, so the enrolled patients may
die from causes other than breast cancer, especially for elderly patients who may die
from aging. Those deaths from other causes can obscure the accurate estimation of
survival probability and cure fraction, because those patients dying from other causes
may also benefit from the treatment of breast cancer.
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Lung Cancer Data
From the SEER 1975-2016 Research Database (Howlader et al., 2019), we also select
a subset of the data for the Louisiana localized lung cancer study. This data set
contains subjects aged at least 50 from the state of Louisiana whose diagnosis year
is between 2004 to 2016. The response variable of interest is the time to death since
diagnosis, for which right-censored data are available since not all patients died by
2016. Our data set only focuses on the data from white and black races although
there are many other races in the original data set.
In total, there are 9,965 observations in this data set, and the right-censored rate
is 42.76%. We consider three covariates of interest: “sex” taking 1 for female and
0 for male, “race” taking 1 for black race and 0 for white race, and “grade”, which
is a measurement of how closely the tumor cells resemble lung ranging from 1 to 9
representing different degrees of differentiation.
1.3 Survival Models
For the past decades, survival analysis has been adapted for application in different
areas such as biology and biomedical studies. We denote by T the random variable
for a subject’s survival time, which is a non-negative continuous variable. We also
denote by t any specific value of interest for the random variable T . For example, if
we are interested in studying whether a patient survives for more than 5 years after
undergoing cancer therapy, then t = 5. Specifically for right-censored data, let Y be
the observation time of patients and C denote their censoring time. Let δ denote
a random variable with possible values 0 and 1 which indicates either censoring or
failure. That is, δ = 1 for failure if the event of interest occurs during a study, or δ = 0
if the survival time is censored by the end of a study. We have Y = T if a subject’s
exact survival time is observed and Y = C if it is censored, i.e., Y = min(T,C) and
δ = I(T ≤ C).
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The cumulative distribution function of T is F (t) = P (T ≤ t) and its correspond-
ing probability density function is denoted as f(t). The survival function of T is the
probability that a subject survives longer than some specified time t, given by
S(t) = P (T > t) = 1− F (t) =
∫ ∞
t
f(s)ds, 0 < t <∞.
The survival functions are nonincreasing and head-downward as t increases. At time
t = 0, S(t) = S(0) = 1.
The hazard function gives the instantaneous potential per unit time for the event
of interest to occur given that the subject has survived up to time t, which is expressed
as
λ(t) = lim
∆t→0
P (t ≤ T < t+ ∆t|T ≥ t)
∆t .
The relationship between survival function S(t) and hazard function λ(t) is
λ(t) = f(t)
S(t) = −
d logS(t)
dt
and
S(t) = exp {−
∫ t
0
λ(s)ds} = exp {−Λ(t)},
where Λ(t) is the cumulative hazard function until time t.
Below are some popular survival models which are used to estimate the effect of
potential covariates on the survival time of patients.
1.3.1 the Proportional Hazards Model
One of the most important statistical models in survival analysis is the proportional
hazards (PH) model proposed by Cox (1972). The PH assumption introduces covari-
ates into the model and specifies the hazard function in the following form,
h(t|x) = h0(t) exp(βᵀx),
where h(·|x) is the hazard function with covariates x, h0(·) is the baseline hazard
function with x = 0, and β is a vector of covariate coefficients. This model has
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proportional hazards with respect of the covariates x such that the hazard ratio
for individuals with x1 and x2 is exp {βᵀ(x1 − x2)}, which is constant over time.
Therefore, the Cox PH model essentially assumes that the treatment effect is constant
over time. The cumulative hazard function in the PH model is the integral of baseline
hazard function, defined as H(t|x) =
∫∞
0 h(t|x)dt, and the logarithm of cumulative
hazard function is expressed as
log {H(t|x)} = βᵀx + log {H0(t)},
which shows that the curves log {H(t|x)} for different values of x are parallel.
For estimation in the PH model, Cox (1975) proposed the partial likelihood to
estimate parameters β without involving the baseline function h0(t), which is the most
popular estimation approach in survival analysis for right-censored data. Suppose we
observe (Yi, δi, xi) for individual i = 1, . . . , n, where Yi is a observed failure time
random variable, δi is the failure/censoring indicator (1=failure, 0=censoring), and
xi represents a vector of covariates. Assume that there are K distinct failure times
and there are no ties among these event times. Let t(1) < t(2) < · · · < t(K) represent
the K ordered distinct failure times, and x(i) is the covariates for the subject that
has the failure at time t(i). Let R(t) = {i : Yi ≥ t} denote the at-risk set at time t,
the partial likelihood for the Cox PH model is
L(β) =
K∏
i=1
exp {βᵀx(i)}∑
j∈R(ti) exp (βᵀxj)
. (1.1)
The partial maximum likelihood estimator of β is found by solving the partial
likelihood score equation obtained by setting the derivative of the partial likelihood
(1.1) with respect to β to 0 in the following form
K∑
i=1
x(i) −
K∑
i=1
∑
j∈R(ti) xj exp (βᵀxj)∑
j∈R(ti) exp (βᵀxj)
= 0.
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1.3.2 the accelerated failure time model
While the Cox PH model specifies that the effect of covariates is multiplicative with
respect to the hazard, the accelerated failure time (AFT) models are that the effect of
covariates is multiplicative or proportional with respect to survival time. The survival
time T in the AFT models maintain the following relationship with covariates
log T = βᵀx + ε,
where x is a vector of covariates and ε are independent random errors. Different
parametric distributions can be assumed for ε to generate different survival functions.
Maximum likelihood estimation can be applied in the AFT models.
1.3.3 the proportional odds model
When the effect of covariates diminishes over time in two-sample cases, one possibility
is to use time-dependent covariates in the Cox PH model. Alternatively, one may use
the proportional odds (PO) model (Bennett, 1983a). The PO model assumes that
the odds ratio remains constant over time. The odds ratio is the ratio of failure odds
of getting the event by time t for different groups, and the failure odds is denoted by
F (t)/1− F (t). The PO model specifies that given covariate x, the odds for survival
at time t is
F (t|x)
1− F (t|x) =
F0(t)
1− F0(t)
exp (βᵀx),
where F0(t) is an unknown baseline cumulative distribution function. The hazard
function given x is
λ(t|x) = exp (β
ᵀx)
exp (βᵀx)R(t) + 1
dR(t)
dt
,
where R(t) = F0(t)/(1− F0(t)). Hence for two different sets of covariates x1 and x2,
the hazard ratio λ(t|x1)/λ(t|x2) approaches unity as time t increases.
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1.3.4 the generalized odds-rate model
The generalized odds-rate (GOR) models was proposed by Harrington and Fleming
(1982) and its survival function is expressed as
S(t|x) = {1 + ρΛ0(t) exp(βᵀx)}−ρ
−1
, t > 0. (1.2)
In the GOR survival function, Λ0(t) is a strictly positive increasing function, β
is a p × 1 vector of regression parameters denoting the covariate effects and ρ is
a positive constant. Specifically, as ρ → 0, equation (1.2) has a limiting survival
function S(t|x) = exp {−Λ0(t)}exp (β
ᵀx) = S0(t)exp (β
ᵀx), which is the survival function
under the Cox PH model. When ρ = 1, equation (1.2) becomes the PO model survival
function S(t|x) = {1 + Λ0(t) exp (βᵀx)}−1.
Previous studies in the GOR models are mainly focused on estimating regression
parameters β by fixing the parameter ρ and selecting model by Akaike information
criterion (AIC) or Bayesian information criterion (BIC), for example, in Cheng, Wei,
and Ying (1995); Cheng, Wei, and Ying (1997); Scharfstein, Tsiatis, and Gilbert
(1998); Fine, Ying, and Wei (1998); Slud and Vonta (2004); Dabrowska (2006) and
Yin and Zeng (2006), among others. The regression parameters β and the increasing
function Λ0(t) can be estimated by maximum likelihood estimation.
1.3.5 Cure Models
Although the Cox PH model and the partial likelihood estimation approach are widely
used due to its fast computation and easy interpretation. In practical circumstances,
the proportional hazards assumption may not be satisfied.
With the rapid development of medication, more and more diseases and even
cancers are curable in the long run such as breast cancer and colon cancer, thus,
there is a proportion of patients may never experience the event of interest for a long
time. The Kaplan-Meier curve will level off and reach a plateau at the end of the
11
study to indicate the cure. The classic cure models are used to address this issue, and
two commonly adopted cure models are the mixture cure model and the promotion
time cure model.
Mixture Cure Model
The mixture cure model was first proposed by Berkson and Gage (1952) and previous
research in literature include Gray and Tsiatis (1989), Kuk and Chen (1992), Sy and
Taylor (2000), Peng and Dear (2000), Betensky and Schoenfeld (2001), Lambert
(2007), Cai et al. (2012), Ortega et al. (2014) among others. The mixture cure model
is expressed as
Spop(t|x, z) = π(z)S(t|x) + 1− π(z), (1.3)
where 1 − π(z) is the probability of the subjects being cured depending on the co-
variates z, and S(t|x) is referred to as a latency survival function, which is the
survival probability of the uncured patients depending on the covariates x. Note
that π(z) can take different link functions such as the logit link function π(z) =
exp (γᵀz)/{1 + exp (γᵀz)}, the log-log link function log
[
− log{1− π(z)}
]
, and the
probit link function Φ−1{π(z)} = γᵀz, where Φ(·) is the cumulative distribution func-
tion of standard normal distribution. If the PH model is used to model the latency
survival function S(t|x), the mixture cure model is called the mixture cure PH model.
Promotion time cure model
The promotion time cure model was initially motivated by a biological model to
analyze the time-to-relapse in cancer studies (Andrei and Asselain, 1996; Tsodikov,
1998 Chen, Ibrahim, and Sinha, 1999; Tsodikov, Ibrahim, and Yakovlev, 2003; Yin
and Ibrahim, 2005). For ith individual with covariates zi, the survival function for
individual i is given by
Spop(t|zi) = exp {−θ(zi)F (t)}, (1.4)
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where θ(·) is a link function and F (t) is a latency cumulative distribution function.
The corresponding latency survival function is denoted by S(t) = 1 − F (t), and
the latency probability density function is f(t) = dF (t)/dt. The cure fraction is
Spop(∞|zi) = exp {θ(zi)} when time goes to infinity, and the cure fraction is always
positive. The promotion time cure model is strongly motivated by biological con-
siderations of tumour cells. For the patient i, let Ni be the number of tumour cells
which have the potential of metastasizing (metastasis-competent tumour cells), and
it is assumed that Ni has a Poisson distribution with mean θ(zi). The promotion time
for the kth (k = 1, . . . , Ni) tumour cell is denoted as T̃k, which is the time for the
kth metastasis-competent tumour cell to produce a detectable tumour mass. Assume
that T̃k’s are independent and identically distributed with the cumulative distribution
function of F (t) conditional on Ni. Note that both Ni and T̃k are unobserved latent
variables which can be explored by Expectation-Maximization (EM) algorithm. The
time to relapse of cancer is defined as Ti = min(T̃1, . . . , T̃Ni). The survival function
can be further written as
Spop(t|zi) = P (Ti > t)
= P (Ni = 0) +
∑
k≥1
P (T̃1 > t, . . . , T̃Ni > t|Ni = k)P (Ni = k)
= exp {−θ(zi)}+
∞∑
k=1
S(t)k θ(zi)
k exp {−θ(zi)}
k!
= exp {−θ(zi)F (t)}.
(1.5)
The corresponding hazard rate for the subject i is θ(zi)f(t) and the link function
θ(zi) usually takes the exponential form exp(γᵀzi). To be consistent with (1.3) in the
mixture cure model, (1.5) is also to allow F (t) to depend on a vector of covariates xi,
leading to
Spop(t|zi,xi) = exp {−θ(zi)F (t|xi)}. (1.6)
The mixture cure model and promotion time cure model are the most widely used
cure fraction models in application and each has its own advantages as well as draw-
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backs as discussed in Chen, Ibrahim, and Sinha (1999) and Ibrahim, Chen, and Sinha
(2001). The mixture cure model is more straightforward to interpret since it involves
two parts to indicate cured and uncured patients. From the Bayesian perspective,
when a uniform improper prior is set for the parameters γ, the posterior distribution
for γ is proper only in the promotion time cure model but is improper in the mixture
cure model. When including the covariates z through the link function for π via a
standard binomial regression model, (1.3) yields improper posterior distributions for
many types of noninformative improper priors, including the uniform prior.
1.4 Existing Regression Approaches
There are many new emerging approaches proposed in the past decades for analyzing
right-censored data, and the ultimate goal is to estimate the covariate effects on the
survival time. Parametric models work well only when the distribution of baseline
functions are correctly specified, but semiparametric regression models are more pre-
ferred in application since they would avoid the problem of misspecification and gain
much modeling flexibility.
The partial likelihood function in equation has eliminated the infinite dimen-
sional baseline hazard function from the estimation of regression parameters for right-
censored data. Andersen and Gill (1982) established the asymptotic properties of the
maximum partial likelihood estimator. Breslow (1972) proposed the nonparamet-
ric estimator for cumulative baseline hazard function via counting process martingale
theory. This type of estimator is called nonparametric maximum likelihood estimator
(NPMLE). When the proportional hazards assumption is violated, Bennett (1983b)
proposed a semiparametric maximum likelihood estimator (MLE) for estimating the
regression parameters in the PO model. Parzen and Harrington (1993) used adaptive
splines with small number of knots to estimate baseline odds of failing by time. The
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NPMLE based on the profile likelihood function was studied in Murphy, Rossini, and
Vaart (1997).
For the more generalized GOR models, Cheng, Wei, and Ying (1997) proposed a
semiparametric approach to estimate the regression parameters. Scharfstein, Tsiatis,
and Gilbert (1998) studied the NPMLE for the regression parameters conditional on
ρ being fixed and known. Chen, Jin, and Ying (2002) developed simple martingale-
based estimating equations to estimate regression parameters. The theoretical prop-
erties and hypothesis tests of the NPMLE for general transformation models have
been studied by Bagdonavicius and Nikulin (1999), Kosorok, Lee, and Fine (2004),
Zeng and Lin (2006) and Song, Kosorok, and Fine (2009).
For the cure models estimation, parametric models and flexible parametric mod-
els usually adapt Newton-Raphson algorithm to maximize the observed likelihood
function. In semiparametric cure models, EM algorithm is used to estimate parame-
ters and cure fraction. The EM algorithm was first introduced by Dempster, Laird,
and Rubin (1977) (DLR). The DLR paper makes significant contributions such that
it recognizes the expectation step (E-step) and the maximization step (M-step), it
gives theoretical properties of the EM algorithm and it also provides a wide range
of applications in statistics. The EM algorithm has become a very popular com-
putational method in statistics for both frequentists and Bayesian approaches. The
implementation of the E-step and M-step is easy for many statistical problems and
even for complex models. The M-step can be performed by existing R packages such
as “optim” or “nleqslv” which makes the algorithm more computationally efficient.
Moreover, the EM algorithm does not require large storage space. Louis (1982) pro-
posed the observed information matrix for the EM algorithm, and it provides the
variance estimation in closed form which makes the EM algorithm even more appeal-
ing.
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The most crucial deterrent in the MLE is the potentially unlimited dimension in
semiparametric regression models. The Newton-Raphson method in maximizing the
full likelihood function requires O(d3) (d is the number of parameters) operations
to solve a system of score equations. The principal part of the d parameters in
a semiparametric regression model is to specify a stepwise function H which may
approach the true continuous function as d goes to infinity. A large d will make the
maximization by Newton-Raphson method has high complexity and is very difficult
in computation. On the contrary, the EM algorithm handles the H function in an
O(d) way.
The EM algorithm can be extended to involve a profile likelihood, such that the
E-step involves computation of the expectation of full likelihood function with respect
to the observed data, and the M-step is to estimate covariate effects using the profile
likelihood in Johansen (1983). Let θ = (β, H), where β is a vector parameters of
interest and H is the stepwise function of a nuisance vector parameters. We denote
O as the observed data. The profile likelihood of β is the likelihood function defined
as
Lp(β;O) = supHL(β,H ;O).
1.5 Structure of the Dissertation
The rest of the dissertation is structured as follows. In Chapter 2, we will study
the mixture cure PH model with background mortality (MCPH+BM) and its com-
putational estimation approach. An EM algorithm with latent variables to indicate
uncured status is developed to estimate the semiparametric MCPH+BM model, and
a perturbation variance estimation method is also discussed. The implementation of
R functions in the “psmcure” package published in Github is further described. The
results of comprehensive simulation studies and a real data application are provided
to evaluate the performance of the proposed method. In Chapter 3, we propose an
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EM algorithm to estimate cure fraction in the promotion time cure PH model with
background mortality (PCPH+BM). The simulation studies show that the proposed
semiparametric method is robust to different data distributions. A real data exam-
ple is provided to illustrate the proposed method and compare the estimation to the
case when background mortality is ignored. A generalization of transformation model
with background mortality is further considered. In Chapter 4, we discuss the identi-
fiability problems in the GOR models and propose a novel EM algorithm to estimate
all the regression parameters and the parameter ρ simultaneously.
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Chapter 2
Semiparametric Estimation of the Cure
Fraction in Population-based Cancer Survival
Analysis
Abstract
With rapid development in medical research, the treatment of diseases including can-
cer has progressed dramatically and those survivors may die from causes other than
the one under study, especially among elderly patients. Motivated by the SEER
female breast cancer study, background mortality is incorporated into the mixture
cure proportional hazards (MCPH) model to improve the cure fraction estimation in
population-based cancer studies. Here, that patients are “cured” is defined as when
the mortality rate of the individuals in diseased group returns to the same level as
that expected in the general population, where the population level mortality is pre-
sented by the mortality table of the United States. The semiparametric estimation
method based on the EM algorithm for the MCPH model with background mortality
(MCPH+BM) is further developed and validated via comprehensive simulation stud-
ies. Real data analysis shows that the proposed semiparametric MCPH+BM model
may provide more accurate estimation in population-level cancer study.
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2.1 Introduction
The treatment of diseases including cancer has progressed dramatically and results
in a high survival probability. The 5-year relative survival probability is as high as
98.2% for thyroid cancer, 98.0% for prostate cancer, 89.9% for female breast cancer,
and 64.4% for colorectal cancer from the Surveillance, Epidemiology, and End Results
(SEER) Program (2009-2015) (Howlader et al., 2019). In the long follow-up time,
those survivors may die from causes other than the one under study, especially in the
case of many elderly patients in a study (Verheul et al., 1993), which may obscure
the estimation of survival probability of interest.
Relative survival is a net survival measurement representing cancer survival in the
absence of other causes of death. It helps to evaluate heath care effectiveness for the
whole population or segments of the population. Relative survival was proposed by
Esteve et al. (1990) such that observed survival probability is the product of corrected
survival probability and expected survival probability, and observed hazard rate is
the sum of corrected hazard rate and excess hazard rate. Previous studies are mainly
focused on how to model the excess hazard. Giorgi et al. (2003) developed a B-splines
relative survival regression model to model hazard ratios. Dickman et al. (2004) pro-
posed a generalized linear model to estimate additive hazards. Stare, Pohar, and
Henderson (2005) addressed the goodness of fit problem of relative survival model.
Pohar and Stare (2006) developed a R package “relsurv” to apply several relative
survival regression models. Nelson et al. (2007) proposed a model restricted cubic
splines on the log cumulative excess hazard scale to estimate the relative survival
and excess mortality rates. Perme, Henderson, and Stare (2008) used EM algorithm
by treating the cause of death as missing data which is a generalization of the Cox
PH model and provides flexibility in baseline excess hazard estimation and they fur-
ther proposed a new estimator of net survival probability that enables comparability
between countries.
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A similar situation that patients may suffer from other events is competing risk
(CR), which is an event either hinders the observation of the event of interest or alters
its probability of occurrence (Gooley et al., 1999). The information from CR event
is needed to derive the subdistribution function and marginal function of the event
of interest. When the event of interest is death, the main difference between relative
survival and competing risk rests on whether the other causes of death are known.
In this paper we consider the case when death is all-cause death rather than causes-
specific death, therefore the relative survival model is more appropriate. We propose
the cure fraction estimation with background mortality based on the structure of
relative survival.
Cure models have been employed to analyze cancer studies with potentially cured
patients. In the standard cure models, “cure” is defined as patients will never ex-
perience the event of interest in the future with a probability of one (Boag, 1949).
The standard mixture cure model is for the case when the specific cause of death is
recorded, so death is disease-related death. In competing risk, at least two causes
of death are known and included in the analysis. However, when the cause of death
is unknown or not recorded, the influence of mortality due to other causes should
be incorporated. De Angelis et al. (1999) proposed the new definition of “cure” in a
population level, that is, the mortality risk of cured patients will return to the similar
mortality risk as their counterpart in the general population, which is referred to as
background mortality. The mixture cure model with background mortality which
incorporates the mortality of general population is more appropriate to this type of
studies than the standard mixture cure model, since it accounts for the mortality due
to other causes (Lambert et al., 2006). Thus, it can improve accuracy in estimat-
ing the survival probability of uncured patients and cure fraction. The background
mortality can be defined via a population-level life table with matched sex and age.
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De Angelis et al. (1999) incorporated the background mortality into the mixture
cure proportional hazards (MCPH) model under the exponential and Weibull distri-
butions for uncured patients. Phillips, Coldman, and McBride (2002) extended De
Angelis’s model to estimate the prevalence of cancer. Sposto (2002) described three
link functions for the cure fraction estimation. Lambert et al. (2006) incorporated
the background mortality to the parametric Weibull cure model via Newton-Raphson
algorithm which is implemented in STATA (Lambert, 2007). They (Lambert et al.,
2010) also have proposed a finite mixture of Weibull distributions to add flexibility,
which also adds the complexity of estimating more Weibull parameters. Royston and
Lambert (2011) discussed different topics such as time-dependent and continuous
covariates in relative survival. Andersson et al. (2011) proposed to use flexible para-
metric survival model with cubic splines to estimate cure fraction in population-based
studies, which however do not allow covariates included in cure fraction function. All
these previous studies on cure model with background mortality used maximum like-
lihood function to estimate parameters and cure fraction.
Even though there are discussions on semiparemetric estimation methods of the
MCPH model (Cai et al., 2012; Peng and Dear, 2000), few work is available in the
literature on the semiparametric estimation method for the MCPH model with back-
ground mortality. In addition, it is well understood that there are limitations in
parametric and flexible parametric estimations, because the appropriate parametric
distribution is hard to specify and the number of knots and degree of splines have to
be selected. The purpose of this paper is to fill the gap in the study of semiparametric
estimation method in the mixture cure model with background mortality. The rest
of the paper is organized as follows. Section 2.2 illustrates the MCPH model with
background mortality (MCPH+BM). The semiparametric estimation method are de-
scribed in Section 2.3. Section 2.4 outlines the simulation studies and Section 2.5
applies the proposed method to the real data. Section 2.6 provides some conclusions.
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2.2 Mixture Cure Model with Background Mortality
Similar to the mixture cure model, the mixture cure model with background mortality
has two components:
1. patients being cured, whose mortality risk will return to the similar mortality
risk level as their counterpart in the general population;
2. uncured patients, who will not only have the risk of death from disease of
interest, but also suffer from the similar mortality risk as their counterpart in
the general population.
Let t denote failure time, h∗(t) and S∗(t) are the population-level hazard risk which
is also called background mortality rate, and the corresponding background survival
probability as their counterpart in the general population with matched sex and
age. Denote hu(t) and Su(t) as the hazard rate of the disease of interest and the
corresponding survival probability. For cured patients, the hazard rate is h∗(t) with
survival probability of S∗(t); for uncured patients, the hazard risk is h∗(t)+hu(t) with
survival probability of S∗(t)Su(t). Let us assume the proportion of cured patients is
indicated by (1−π). The mixture cure model with background mortality is expressed
as
Spop(t) = πS∗(t)Su(t) + (1− π)S∗(t).
The corresponding population-level hazard function is expressed as
hpop(t) = h∗(t) +
πfu(t)
πSu(t) + 1− π
,
where fu(t) is the probability density function associated with the survival function
Su(t). Note, the model reduces to the standard mixture cure model when S∗(t) = 1 or
h∗(t) = 0, which is the mixture cure model ignoring background mortality risk. The
second component in the population-level hazard function πfu(t)/{πSu(t) + 1 − π}
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is the corresponding hazard function for the standard mixture cure model. The
hazard function of the mixture cure model with background mortality is intuitively
the summation of the background hazard rate and the disease-related hazard rate.
Let z denote a vector of covariates, which may impact the uncured fraction, and
the model turns to the mixture cure model with background mortality (Lambert et
al., 2006; Lambert, 2007) such that
Spop(t) = S∗(t){π(z)Su(t) + 1− π(z)}, (2.1)
where π(z) can be modeled via the logistic link, log-log link or probit link. Let x
denote a vector of covariates having potential effects on the latency survival func-
tion Su(t). It is worthwhile pointing out that the same covariates are allowed for
x and z although we use different covariate notations, which is more flexible than
existing methods. When Su(t) is specified via the proportional hazards assumption
of Su(t|x) = S0(t)exp(β
ᵀxi), equation (2.1) turns to the MCPH model with background
mortality (MCPH+BM) (De Angelis et al., 1999; Royston and Lambert, 2011), which
is written as
Spop(t) = S∗(t){π(z)S0(t)exp(β
ᵀxi) + 1− π(z)}.
Similarly, as S∗(t) = 1 or h∗(t) = 0, equation (2.1) reduces to the standard MCPH
model.
Let Oi = (ti, δi, zi,xi) denote the observed data for subject i = 1, 2, . . . , n, where
ti is the observed survival time with recorded death of any cause as the event of
interest. δi is the censoring indicator with 1 for death and 0 for right censoring, zi is
a vector of covariates which have potential effects on the uncured fraction, and xi is a
vector of covariates for the survival probability of uncured patients. We assume that
right censoring is independent provided that it is random and non-informative such
that the distribution of survival times provides no information about the distribution
of censoring times. Let Θ = {γ,β, S0(·), h0(·)} denote the unknown parameters,
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where γ is the vector of unknown parameters in π(z), β are the coefficients in Su(ti),
S0(·) and h0(·) are the baseline survival and baseline hazard functions in Su(t), so the
observed likelihood function in the MCPH+BM model is
Lobs(Θ; O) =
n∏
i=1
[
π(zi)S0(ti)exp(β
ᵀxi){h∗(ti) + h0(ti) exp(βᵀxi)}+ {1− π(zi)}h∗(ti)
]δi
× S∗(ti)
[
π(zi)S0(ti)exp(β
ᵀxi) + {1− π(zi)}
]1−δi
.
Note that both h∗(ti) and S∗(ti) are assumed to be sex and age matched constant
values for the subject i. In this paper they are obtained by matching sex and age
for each individual from a life table (Coleman et al., 1999), so both h∗(ti) and S∗(ti)
are not affected by the modeled parameters. For application, the overall background
mortality can also be used. Once S0(ti) is fully specified as in a parametric struc-
ture, it can be estimated directly via MLE algorithm (Lambert et al., 2006) or EM
algorithm. However, in practice it is often hard to find an appropriate parametric
structure or such parametric structures do not even exist. In these situations, the
proposed semiparametric approach in this paper can be applied. We will discuss the
details of our estimation approach for the MCPH+BM model in the following section.
2.3 EM Algorithm
Similar to in the standard MCPH model (Sposto, 2002), we use a logistic link function
for the uncured fraction in the MCPH+BM model. Other link functions such as log-
log link and probit link can also be applied. Let y be the latent uncured indicator,
with y = 1 indicating uncured patients and y = 0 indicating cured patients. The
uncured probability under the logistic link function is expressed as
P (y = 1|z) = π(z) = exp(γ
ᵀz)
1 + exp(γᵀz) .
Note that y is partially missing in the standard MCPH model because when a
patient is cured with yi = 0, this person only can be censored (δi = 0) and no
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longer suffers from the disease under study. However, y is completely missing in the
MCPH+BM model, because patients die from other causes may also benefit from the
treatment of disease and has the possibility to be cured. There are four components
contributing to the complete likelihood function, π(zi)S∗(ti)S0(ti)exp(β
ᵀxi){h∗(ti) +
h0(ti) exp(βᵀxi)} which indicates that a patient is uncured and dead from the disease
under study, {1 − π(zi)}S∗(ti) which is a quantity for a cured censored patient,
π(zi)S∗(ti)S0(ti)exp(β
ᵀxi) which is a quantity for a uncured censored patient, and {1−
π(zi)}h∗(ti)S∗(ti) which indicates a patient is cured of the disease under study but
dead from background mortality.
The complete likelihood function is then written as
Lc(Θ; O,Y) =
n∏
i=1
[
{1− π(zi)}h∗(ti)δiS∗(ti)
](1−yi)
[
π(zi)S∗(ti)S0(ti)exp(β
ᵀxi){h∗(ti) + h0(ti) exp(βᵀxi)}δi
]yi
,
and the logarithm of the complete likelihood function is
`c(Θ; O,Y) =
n∑
i=1
(1− yi) log{1− π(zi)}+ yi log{π(zi)}+ yi log{S0(ti)exp(β
ᵀxi)}
+ yi log{S∗(ti)}+ δiyi log{h∗(ti) + h0(ti) exp(βᵀxi)}
+ (1− yi) log{h∗(ti)δiS∗(ti)}.
(2.2)
The main components associated with unknown parameters γ and β in equation (2.2)
can be expressed as the sum of two parts `c1(γ; z,Y) + `c2{β, S0(·), h0(·); t, δ,x,y}
with
`c1(γ; z,y) =
n∑
i=1
yi log{π(zi)}+ (1− yi) log{1− π(zi)} (2.3)
`c2{β, S0(·), h0(·); t, δ,x,y} =
n∑
i=1
yi log{S0(ti)exp(β
ᵀxi)}
+ δiyi log{h∗(ti) + h0(ti) exp(βᵀxi)}
(2.4)
where y = (y1, y2, . . . , yn) are the vector of uncured indicators.
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In the EM algorithm, the E-step is to take conditional expectations of equation
(2.3) and (2.4) with respect to yi’s given the observed data O and parameters Θ. For
the subject i, yi is either 1 or 0 no matter what value δi is. Thus, yi|δi = 1 follows a
Bernoulli distribution with the probability of success
π(zi)S∗(ti)S0(ti)exp(β
ᵀxi){h∗(ti) + h0(ti) exp(βᵀxi)}
{1− π(zi)}h∗(ti)S∗(ti) + π(zi)S∗(ti)S0(ti)exp(βᵀxi){h∗(ti) + h0(ti) exp(βᵀxi)}
,
and yi|δi = 0 follows a Bernoulli distribution with the probability of success
π(zi)S∗(ti)S0(ti)exp(β
ᵀxi)
{1− π(zi)}S∗(ti) + π(zi)S∗(ti)S0(ti)exp(βᵀxi)
.
Let ωi denote the conditional expectation of yi given the observed data O and pa-
rameters Θ, one has
ωi =E(yi|Θ,O)
=δi
π(zi)S∗(ti)S0(ti)exp(β
ᵀxi){h∗(ti) + h0(ti) exp(βᵀxi)}
{1− π(zi)}h∗(ti)S∗(ti) + π(zi)S∗(ti)S0(ti)exp(βᵀxi){h∗(ti) + h0(ti) exp(βᵀxi)}
+(1− δi)
π(zi)S∗(ti)S0(ti)exp(β
ᵀxi)
{1− π(zi)}S∗(ti) + π(zi)S∗(ti)S0(ti)exp(βᵀxi)
.
(2.5)
The conditional expectations of equation (2.3) and (2.4) with respect to ωi’s given
the observed data O and parameters Θ are
E{`c1(γ; z,ω)} =
n∑
i=1
ωi log{π(zi)}+ (1− ωi) log{1− π(zi)} (2.6)
and
E
[
`c2{β, S0(·), h0(·); t, δ,x,ω}
]
=
n∑
i=1
ωi log{S0(ti)exp(β
ᵀxi)}
+ δiωi log{h∗(ti) + h0(ti) exp(βᵀxi)}.
(2.7)
The M-step in the EM algorithm is to maximize equation (2.6) and (2.7) via
Newton-Raphson method using “optim” function in R. Note that equation (2.6) only
contains the unknown parameters γ and equation (2.7) only involves the unknown
parameters β, S0(·) and h0(·). Thus, the expectation of the logarithm complete
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likelihood can be maximized by equations (2.6) and (2.7) separately, which improves
computation efficiency. The background hazard rate h∗(t) and background survival
probability S∗(t) are sex and age matched constant pieces in the calculation of EM
algorithm.
Let t(1) < t(2) < · · · < t(k) be the distinct ordered uncensored failure times and
R{t(j)} be the risk set at the time point t(j). Assume the hazard rate only jumps at
these event times. Given β and ωi, we take the first partial derivative of equation (2.7)
with respect to h0(ti;β, ωi), which is ∂E
[
`c2{β, S0(·), h0(·); t, δ,x,ω}
]
/∂h0(ti;β, ωi) =
0. Then equation (2.7) can be maximized at the following baseline hazard function
(Peng and Dear, 2000; Breslow, 1972)
h0(ti;β, ωi) =
δiωi∑
l∈R(ti) ωl exp(βᵀxl)
− h
∗(ti)
exp(βᵀxi)
, (2.8)
and the baseline survival function
S0(ti;β, ωi) = exp
(
−
∑
j:t(j)≤ti
[ δ(j)ω(j)∑
l∈R{t(j)} ωl exp(βᵀxl)
−
h∗{t(j)}
exp{βᵀx(j)}
])
. (2.9)
Given estimated baseline functions in equation (2.8) and (2.9), β can be updated by
maximizing equation (2.7).
Remark: The equation (2.6) is exactly the same as the first expectation of the log-
arithm complete likelihood function in the standard MCPH model (Peng and Dear,
2000; Sy and Taylor, 2000), but the equation (2.7) involves the background hazard
risk, which is different from the formula in the standard MCPH model. The com-
plexity in the equation (2.7) makes the calculation of ωi in the equation (2.5) more
complex. Specifically, in the standard MCPH model, ωi = 1 when δi = 1, since a
dead patient is uncured. However, in the proposed MCPH+BM model when δi = 1,
a patient not only may die from the disease under study, but also may be cured of the
disease under study and die from background mortality. Moreover, in the standard
MCPH model, the baseline hazard function only takes the first quantity in the for-
mula (2.8), but in the MCPH+BM model, patients also suffer from the background
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hazard risk which is the second quantity in the formula (2.8). Thus, the corresponding
baseline survival function becomes more complex as shown in (2.9).
Previous studies have discussed the identifiability issue in the standard mixture
cure model. Li, Taylor, and Sy (2001) explored the mixture cure model with or
without covariates in the cure fraction and the latency distribution, and theoretically
showed that the mixture cure model is identifiable except for the case when the la-
tency distribution is independent of covariates. Specifically, the mixture cure model
is not identifiable when the cure fraction is not modeled by covariates. Yu et al.
(2004) studied the identifiability of the mixture cure model for the grouped survival
data and found the cure fraction estimates can be sensitive to the latency survival
distributions. If the largest survival time is censored, the estimated survival proba-
bility at the time between the largest uncensored time and the largest time is equal
to the survival probability at the largest uncensored time, which leads to an improper
distribution. Consequently in the estimation of nonparametric baseline function, the
model is overparameterized such that the intercept term in the logistic predictor
and the improper distribution of uncured patients are not identifiable. Sy and Tay-
lor (2000) and Peng and Dear (2000) apply the zero tail constrains in the standard
MCPH model. Similarly, we impose the Taylor tail completion (zero-tail constraint)
(Taylor, 1995) on the total baseline survival probability expressed as S∗0(t)S0(t;β,ω),
if there are censored survival times greater than the last survival time, and the total
baseline cumulative hazard function beyond the last survival time is infinity.
The EM algorithm for estimating parameters Θ = {γ,β, S0(·), h0(·)} is summa-
rized as follows,
Step 0: Set initial values ω0i to the subject censoring indicator δi, (i = 1, 2, · · · , n),
initial values γ0 are estimated from the logistic regression with ω0 as response
variable and z as covariates, and initial values β0 are estimated from the Cox
proportional hazards model with x as covariates;
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Step 1: In (k+1) iteration, update γ(k+1) via maximizing (2.6) using “optim” func-
tion;
Step 2: Update β(k+1) via maximizing equation (2.7) using “optim”, where baseline
hazard and baseline survival functions are replaced by (2.8) and (2.9) in
equation (2.7);
Step 3: Update h(k+1)0 {ti;β(k+1), ω
(k)
i } and S
(k+1)
0 {ti;β(k+1), ω
(k)
i } using equation (2.8)
and (2.9); then ω(k+1)i is updated by equation (2.5);
Step 4: Iterate the Step 1-3 until convergence, when the differences of the updated
values in two successive iterations are less than 1e-7.
For variance estimation, let Θ̂ = {γ̂, β̂, Ŝ0(·), ĥ0(·)} denote the converged values
from the EM algorithm, and ω̂i be the last iteration updated value of ωi for the subject
i. In the equation (2.6) and (2.7), the expectation of individual logarithm likelihood
functions for the subject i are E{`c1,i(γ; zi, ωi)} = ωi log{π(zi)}+(1−ωi) log{1−π(zi)}
and E{`c2,i(β, S0(ti), h0(ti); δi,xi, ωi)} = ωi log{S∗(ti)S0(ti)exp(β
ᵀxi)}+δiωi log{h∗(ti)+
h0(ti) exp(βᵀxi)} + δi(1 − ωi) log{h∗(ti)} + (1 − ωi) log{S∗(ti)}. Let Di be the first
derivative of these two expectation logarithm likelihood functions with respect to γ
and β,
Di =
(
∂E{`c1,i(γ; zi, ω̂i)}
∂γ
∣∣∣∣∣
γ̂
,
∂E{`c2,i(β, S0(ti), h0(ti); δi,xi, ω̂i)}
∂β
∣∣∣∣∣
{β̂,Ŝ0(ti),̂h0(ti)}
)′
.
.
The variances of γ̂ and β̂ can be obtained by inverting the empirical Fisher infor-
mation matrix (Murphy and Vaart, 2000) Î = ∑ni=1DiD′i. The first component of Di
is easily obtained because it has a closed form. The second component of Di does not
have a closed form, but it can be approximated by numerical differentiation methods
such as a first-order Richardson extrapolation of the central difference (Jamshidian
and Jennrich, 2000). Thus, the approximation of the second component of Di for the
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jth coefficient in β is expressed as
∂E{`c2,i(β, S0(ti), h0(ti))}
∂βj
≈ 112d
(
E
[
`c2,i{β − 2dv(j), S0(ti), h0(ti)}
]
− 8E
[
`c2,i{β − dv(j), S0(ti), h0(ti)}
]
+ 8E
[
`c2,i{β + dv(j), S0(ti), h0(ti)}
]
− E
[
`c2,i{β + 2dv(j), S0(ti), h0(ti)}
])∣∣∣∣∣
{β̂,Ŝ0(ti),̂h0(ti)}
(2.10)
where d is a small positive value, v(j) is a vector with its jth component equals to 1
and all others equal to 0.
2.4 Simulation Studies
Simulation studies are conducted to evaluate the performance of the proposed semi-
parametric estimation approach in the MCPH+BM model. We compare the perfor-
mance of our proposed model to a flexible parametric method and fully parametric
methods. The flexible parametric method used for comparison is to model the base-
line hazard function by monotone splines with equally spaced knots at percentiles
(Ramsay, 1988) via the EM algorithm in Section 2.3. The degree of splines is set to
3 and the number of knots is selected by Akaike’s information criterion (AIC). The
fully parametric method is to model the baseline hazard rate and baseline survival
probability with the corresponding parametric distributions of Weibull, Lognormal
and Loglogistic via the EM algorithm. We use EM algorithm for fully parametric
method in simulation studies instead of MLE algorithm since it is more reasonable
to be compared under similar algorithm setting.
Note, 1) the existing flexible parametric methods for cure fraction estimation in
population level such as the method proposed by Andersson et al. (2011) can be
implemented by “rstpm2” or “flexsurvcure” functions in R package, and “stpm2”
command in STATA, but those models and packages do not have the same data
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setting as the MCPH+BM model has, specifically the cure fraction can not accom-
modate covariates; 2) With a simulation comparison, the MLE parametric algorithm
with the implementation of Nelder and Mead method requires large number of itera-
tions (5000) and small convergence tolerance (1e-20) to get similar simulation results
as in the EM parametric algorithm (tables are not shown).
We generate the covariates z from a Bernoulli distribution with probability 0.5,
with 0 and 1 as the group indicator. Setting γ to (log(2),−1) gives the cure rate about
33% and 58% for two groups for illustration. Uncured indicators are generated from
a Bernoulli distribution with the probability of uncured fraction. The covariate of
“age” is generated from a normal distribution with mean of 70 and standard deviation
of 5, and “sex” from a Bernoulli distribution with the probability of 0.5.
For a patient being cured, the survival time is generated from the background
mortality distribution. The background mortality is matched based on the estimated
Weibull distribution approximated using “2015 USA Life Table” (Arias and Xu, 2018).
The “2015 USA Life Table” has survival probability for male and female at the age
of 0 to 110. For each sex and age combination, we approximate the life table via a
Weibull distribution and those estimated parameters of Weibull distribution are used
as the background mortality parameters. Then we match the sex and age in the data
set with those in the background mortality table, and use the parameters to generate
survival times from the background mortality.
For the uncured patients who may die from the disease under study or some
other causes, the survival time is the minimum value generated from the background
mortality distribution and the latency proportional hazards model. In the latency
proportional hazards model, we include the covariates of group and sex, and set
their coefficients β to (1,−1). Several baseline survival functions are considered in
the proportional hazards model to simulate data set: 1) Weibull distribution with
shape = 0.75 and scale = 1; 2) Lognormal distribution with mean = 0 and standard
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deviation = 1; and 3) Loglogistic distribution with shape = 2 and scale = 1. Finally,
the censoring time is generated from an exponential distribution exp(c) where the
parameter c controls the censoring rate at about 50%.
We consider a small (n=200), medium (n=400) and large (n=800) sample size
with 500 replicates for each simulation setup. A sensitivity analysis of 800 sample
size is further conducted to illustrate the misspecification in the fully parametric
method through the performance of the proposed semiparametric approach in the
MCPH+BM model and the performance of fully parametric method with correctly
specified and misspecified distributions.
The simulation results including bias, average estimated standard error (StErr),
empirical standard deviation (StDev), 95% coverage probability (CP) and also aver-
age running time per replicate are reported in Table 2.1-2.5. Specifically, biases are
calculated as the average of differences between point estimators and their true val-
ues. StErrs are the average estimated standard errors obtained by the perturbation
method with d = 0.1 in equation (2.10) for the proposed semiparametric approach,
and the Hessian matrix for the flexible parametric and fully parametric methods.
StDevs are the empirical standard deviations of point estimators from the 500 repli-
cates and CPs are the average coverage probabilities of the 95% confidence intervals.
The cure fraction estimation for two groups are also reported.
The results of simulation studies (Table 2.1-2.3) show that the proposed semi-
parametric method performs well in estimating all the parameters and cure fraction
in the MCPH+BM model. The biases for all estimated parameters are small and
the corresponding CPs are close to the nominal 95%, also comparable to the flexible
parametric method when the best number of knots is selected according to AIC, and
the fully parametric methods when correctly specifying the data distributions. Note
that the performance of flexible parametric method via EM algorithm is good when
the best number of knots is selected by AIC, but the computation speed is about
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Table 2.1: Summary Statistics for Weibull Data with Logistic Link: by semiparamet-
ric method, flexible parametric method with monotone splines, parametric Weibull
baseline function.
Semiparametric Flexible Parametric Parametric
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
n=200
γ0 0.073 0.247 0.266 0.938 0.109 0.460 0.394 0.968 0.047 0.293 0.306 0.950
γ1 -0.058 0.334 0.331 0.942 -0.135 0.520 0.457 0.946 -0.037 0.364 0.396 0.932
β1 0.036 0.244 0.290 0.918 0.087 0.295 0.278 0.938 0.047 0.274 0.289 0.946
β2 -0.039 0.267 0.274 0.934 -0.089 0.280 0.285 0.954 -0.026 0.268 0.258 0.966
cure-1 -0.004 0.049 0.051 0.940 0.005 0.054 0.056 0.966 -0.003 0.051 0.054 0.950
cure-2 -0.027 0.052 0.054 0.942 -0.017 0.075 0.073 0.952 -0.007 0.066 0.065 0.940
running time: 1.433 running time: 17.891 running time: 0.726
n=400
γ0 0.057 0.170 0.178 0.932 0.041 0.233 0.233 0.958 -0.004 0.201 0.198 0.956
γ1 -0.046 0.235 0.231 0.941 -0.058 0.277 0.279 0.960 0.024 0.252 0.243 0.948
β1 0.046 0.160 0.176 0.926 0.053 0.192 0.191 0.946 -0.004 0.187 0.187 0.946
β2 -0.027 0.166 0.180 0.930 -0.042 0.187 0.190 0.940 -0.006 0.184 0.188 0.942
cure-1 0.004 0.036 0.036 0.932 0.004 0.036 0.038 0.956 -0.005 0.036 0.035 0.958
cure-2 -0.013 0.036 0.038 0.936 -0.007 0.050 0.050 0.958 0.002 0.043 0.044 0.952
running time: 10.646 running time: 36.340 running time: 1.903
n=800
γ0 0.011 0.128 0.124 0.952 0.009 0.156 0.147 0.958 0.014 0.142 0.137 0.958
γ1 -0.021 0.165 0.161 0.936 -0.011 0.188 0.182 0.946 -0.021 0.177 0.167 0.972
β1 0.025 0.121 0.124 0.934 0.038 0.131 0.140 0.924 0.008 0.130 0.125 0.956
β2 -0.024 0.119 0.124 0.926 -0.045 0.129 0.128 0.934 -0.007 0.128 0.126 0.954
cure-1 0.004 0.025 0.026 0.952 0.000 0.027 0.027 0.956 0.001 0.025 0.025 0.958
cure-2 -0.002 0.029 0.027 0.948 -0.001 0.034 0.032 0.950 -0.003 0.031 0.030 0.962
running time: 12.021 running time: 114.612 running time: 2.990
10 times of that in the proposed semiparametric approach. The standard errors for
the estimated parameters are similar in magnitude for different distributions, and
become smaller when sample size increases from 200 to 400 and then to 800. Thus
the accuracy of parameters estimation gets better with the increase of sample size.
The perturbation method to estimate the variance of estimators works well to pro-
vide desirable standard errors and coverage probabilities, and is also efficient in com-
puting. We also did additional simulation to compare the perturbation method and
bootstrap method for variance estimation (tables are not shown). The results from
bootstrap method are similar to what we obtained from the perturbation method, but
the perturbation method is more computational efficient. In each replicate, it only
takes an average of 0.04 seconds for 200 sample size, 0.10 seconds for 400 sample size
and 0.20 seconds for 800 sample size for variance estimation. On the contrary, the
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Table 2.2: Summary Statistics for Lognormal Data with Logistic Link: by semi-
parametric method, flexible parametric method with monotone splines, parametric
Lognormal baseline function.
Semiparametric Flexible Parametric Parametric
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
n=200
γ0 0.063 0.250 0.273 0.940 0.132 0.562 0.583 0.968 0.010 0.317 0.330 0.952
γ1 -0.080 0.334 0.330 0.948 -0.148 0.619 0.604 0.962 -0.007 0.388 0.416 0.942
β1 0.020 0.270 0.287 0.936 0.104 0.302 0.313 0.929 0.023 0.290 0.294 0.934
β2 -0.025 0.262 0.281 0.930 -0.094 0.283 0.292 0.941 -0.020 0.276 0.297 0.934
cure-1 -0.004 0.050 0.050 0.942 0.003 0.054 0.055 0.966 -0.002 0.056 0.057 0.954
cure-2 -0.017 0.055 0.057 0.942 -0.016 0.081 0.082 0.960 0.002 0.067 0.069 0.948
running time: 1.909 running time: 14.453 running time: 0.795
n=400
γ0 0.041 0.174 0.199 0.934 0.013 0.240 0.239 0.956 0.004 0.217 0.219 0.954
γ1 -0.036 0.249 0.229 0.962 -0.008 0.284 0.273 0.974 -0.001 0.267 0.265 0.950
β1 0.024 0.185 0.195 0.926 0.065 0.194 0.202 0.924 0.011 0.198 0.191 0.960
β2 -0.042 0.193 0.195 0.932 -0.067 0.189 0.197 0.932 -0.019 0.190 0.200 0.938
cure-1 0.006 0.037 0.036 0.936 0.001 0.036 0.036 0.954 -0.001 0.039 0.040 0.954
cure-2 -0.007 0.043 0.043 0.938 0.005 0.051 0.052 0.948 0.001 0.048 0.048 0.950
running time: 4.579 running time: 32.318 running time: 0.933
n=800
γ0 0.023 0.125 0.123 0.944 0.019 0.158 0.151 0.941 0.002 0.153 0.158 0.938
γ1 -0.017 0.167 0.165 0.922 -0.005 0.191 0.187 0.959 -0.003 0.187 0.187 0.950
β1 0.025 0.135 0.134 0.952 0.011 0.130 0.142 0.919 0.010 0.138 0.141 0.934
β2 -0.016 0.130 0.133 0.936 -0.024 0.139 0.141 0.922 -0.012 0.133 0.133 0.944
cure-1 0.009 0.027 0.027 0.944 0.003 0.027 0.027 0.940 -0.000 0.026 0.026 0.938
cure-2 0.006 0.028 0.028 0.940 0.012 0.033 0.034 0.946 0.000 0.035 0.035 0.942
running time: 15.513 running time: 97.027 running time: 1.741
bootstrap method with 100 resamples to estimate variance takes about 1.5 seconds
for a small sample size of 200, which is 37 times slower.
Figures 2.1-2.9 display the average baseline survival probability estimation with
their empirical 95% confidence intervals for different data distributions. The esti-
mated baseline survival probability is close to the true baseline survival function and
the 95% confidence interval becomes narrower with the increase of sample size, which
indicates the proposed method provides a good estimation of the baseline function
under the proposed semiparametric MCPH+BM model. In addition, Figure 2.10-2.12
are the predicted net survival probabilities for two groups when incorporating the co-
variate of group in both cure function and latency survival function which indicates
a long term plateau.
The sensitivity analysis in Table 2.4 has the same data and parameters settings
as those described above with n=800, which shows that the proposed semiparametric
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Table 2.3: Summary Statistics for Loglogistic Data with Logistic Link: by semi-
parametric method, flexible parametric method with monotone splines, parametric
Loglogistic baseline function.
Semiparametric Flexible Parametric Parametric
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
n=200
γ0 0.070 0.325 0.313 0.934 0.010 0.394 0.376 0.968 0.025 0.303 0.319 0.954
γ1 -0.049 0.333 0.371 0.934 -0.029 0.456 0.443 0.952 -0.006 0.374 0.380 0.946
β1 0.007 0.290 0.287 0.928 0.079 0.295 0.305 0.952 0.018 0.287 0.302 0.940
β2 -0.003 0.277 0.281 0.944 -0.084 0.285 0.297 0.926 -0.023 0.271 0.272 0.956
cure-1 -0.006 0.050 0.051 0.934 0.004 0.054 0.056 0.966 -0.005 0.053 0.053 0.954
cure-2 -0.012 0.058 0.059 0.932 0.003 0.075 0.074 0.952 -0.002 0.068 0.068 0.948
running time: 1.356 running time: 33.389 running time: 0.709
n=400
γ0 0.030 0.188 0.185 0.944 0.080 0.224 0.220 0.968 0.016 0.211 0.211 0.958
γ1 -0.057 0.229 0.234 0.946 -0.066 0.271 0.267 0.938 -0.012 0.261 0.249 0.962
β1 0.056 0.166 0.188 0.918 0.031 0.193 0.191 0.950 0.026 0.196 0.193 0.938
β2 -0.016 0.196 0.192 0.940 -0.030 0.190 0.205 0.930 -0.008 0.187 0.183 0.948
cure-1 0.006 0.034 0.034 0.944 0.003 0.037 0.038 0.966 -0.001 0.038 0.038 0.960
cure-2 -0.005 0.041 0.040 0.940 0.020 0.049 0.050 0.940 -0.002 0.046 0.046 0.956
running time: 3.865 running time: 106.963 running time: 1.198
n=800
γ0 0.030 0.131 0.129 0.934 0.024 0.147 0.150 0.940 0.009 0.148 0.144 0.966
γ1 -0.032 0.161 0.171 0.929 -0.010 0.182 0.178 0.964 -0.019 0.183 0.168 0.976
β1 0.023 0.128 0.125 0.940 0.009 0.129 0.137 0.930 0.013 0.135 0.142 0.928
β2 -0.002 0.154 0.146 0.958 -0.020 0.129 0.130 0.948 -0.007 0.131 0.130 0.948
cure-1 0.007 0.025 0.025 0.934 0.003 0.025 0.026 0.942 0.002 0.025 0.025 0.964
cure-2 0.010 0.028 0.029 0.932 0.029 0.034 0.034 0.944 -0.001 0.031 0.032 0.964
running time: 12.647 running time: 137.027 running time: 3.295
Figure 2.1: Baseline Survival Probability Estimation for Weibull Data by Semipara-
metric MCPH+BM Model (200 Sample Size).
method performs better than fully parametric methods. The columns in Table 2.4
denote the true data distributions (Weibull, Lognormal and Loglogistic) while rows
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Table 2.4: Sensitivity Analysis: columns are Weibull, Lognormal and Loglogistic data
distributions; rows are the parametric Weibull, Lognormal, Loglogistic methods and
the proposed semiparametric method.
Weibull Lognormal Loglogistic
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
Weibull
γ0 0.014 0.142 0.137 0.958 -0.102 0.112 0.114 0.836 -0.148 0.111 0.114 0.716
γ1 -0.021 0.177 0.167 0.972 0.095 0.153 0.154 0.900 0.137 0.152 0.152 0.846
β1 0.008 0.130 0.125 0.956 0.070 0.122 0.115 0.926 0.021 0.135 0.111 0.980
β2 -0.007 0.128 0.126 0.954 0.049 0.116 0.123 0.904 0.238 0.130 0.120 0.532
shape 0.005 0.034 0.034 0.954 1.023 0.051 0.020 0.000 -0.972 0.056 0.019 0.000
scale 0.012 0.133 0.131 0.958 0.739 0.153 0.119 0.000 0.763 0.178 0.118 0.000
cure-1 0.001 0.025 0.025 0.958 0.002 0.020 0.024 0.840 0.003 0.022 0.024 0.718
cure-2 -0.003 0.031 0.030 0.962 0.023 0.024 0.026 0.842 0.034 0.025 0.026 0.802
Lognormal
γ0 0.450 0.202 0.153 0.332 0.002 0.153 0.158 0.938 -0.083 0.115 0.116 0.878
γ1 -0.428 0.229 0.183 0.562 -0.003 0.187 0.187 0.950 0.077 0.154 0.149 0.916
β1 0.171 0.162 0.085 0.940 0.010 0.138 0.141 0.934 0.011 0.122 0.102 0.986
β2 0.380 0.131 0.088 0.094 -0.012 0.133 0.133 0.944 0.069 0.116 0.115 0.908
shape -0.750 0.244 0.004 0.000 0.004 0.093 0.095 0.940 -1.972 0.074 0.041 0.000
scale 1.067 0.091 0.121 0.000 -0.003 0.049 0.048 0.964 -0.104 0.034 0.047 0.216
cure-1 -0.006 0.032 0.026 0.330 -0.000 0.026 0.026 0.938 0.001 0.021 0.023 0.880
cure-2 -0.091 0.033 0.028 0.328 0.000 0.035 0.035 0.942 0.019 0.030 0.027 0.876
Loglogistic
γ0 0.367 0.159 0.152 0.348 0.115 0.132 0.123 0.906 0.009 0.148 0.144 0.966
γ1 -0.348 0.191 0.183 0.574 -0.099 0.167 0.160 0.926 -0.019 0.183 0.168 0.976
β1 0.090 0.140 0.115 0.952 0.028 0.121 0.122 0.926 0.013 0.135 0.142 0.928
β2 0.204 0.126 0.107 0.658 -0.038 0.120 0.112 0.952 -0.007 0.131 0.130 0.948
shape 0.206 0.046 0.051 0.002 1.744 0.094 0.081 0.000 0.009 0.106 0.105 0.952
scale -0.268 0.118 0.103 0.380 0.018 0.076 0.078 0.952 0.008 0.073 0.077 0.942
cure-1 -0.005 0.030 0.026 0.346 -0.004 0.028 0.025 0.904 0.002 0.025 0.025 0.964
cure-2 -0.075 0.030 0.029 0.344 -0.024 0.028 0.026 0.904 -0.001 0.031 0.032 0.964
Semiparametric
γ0 0.011 0.128 0.124 0.952 0.023 0.125 0.123 0.944 0.030 0.131 0.129 0.934
γ1 -0.021 0.165 0.161 0.936 -0.017 0.167 0.165 0.922 -0.032 0.161 0.171 0.929
β1 0.025 0.121 0.124 0.934 0.025 0.135 0.134 0.952 0.023 0.128 0.125 0.940
β2 -0.024 0.119 0.124 0.926 -0.016 0.130 0.133 0.936 -0.002 0.154 0.146 0.958
cure-1 0.004 0.025 0.026 0.952 0.009 0.027 0.027 0.944 0.007 0.025 0.025 0.934
cure-2 -0.002 0.029 0.027 0.948 0.006 0.028 0.028 0.940 0.010 0.028 0.029 0.932
Figure 2.2: Baseline Survival Probability Estimation for Weibull Data by Semipara-
metric MCPH+BM Model (400 Sample Size).
36
Table 2.5: Summary Statistics for the proposed semiparametric method with logistic
link (low cure rates)
Weibull Data Lognormal Data Loglogistic Data
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
n=200
γ0 0.058 0.256 0.242 0.946 0.042 0.301 0.292 0.922 -0.071 0.289 0.280 0.940
γ1 -0.046 0.302 0.313 0.940 0.032 0.340 0.332 0.938 0.059 0.341 0.326 0.942
β1 0.002 0.198 0.202 0.926 0.005 0.207 0.212 0.936 0.008 0.251 0.235 0.940
β2 -0.007 0.150 0.168 0.934 -0.009 0.142 0.149 0.920 -0.003 0.154 0.144 0.926
cure-1 -0.004 0.038 0.036 0.946 -0.005 0.040 0.042 0.920 0.002 0.050 0.051 0.938
cure-2 0.008 0.035 0.036 0.942 0.002 0.027 0.028 0.924 0.001 0.038 0.038 0.940
n=400
γ0 0.021 0.182 0.175 0.944 0.018 0.189 0.182 0.930 -0.052 0.179 0.184 0.932
γ1 -0.032 0.208 0.189 0.940 0.032 0.222 0.235 0.918 0.041 0.231 0.228 0.922
β1 0.004 0.130 0.138 0.930 0.005 0.153 0.150 0.942 0.002 0.170 0.168 0.936
β2 -0.005 0.091 0.084 0.926 -0.003 0.092 0.113 0.944 -0.011 0.082 0.090 0.952
cure-1 0.003 0.028 0.029 0.944 -0.003 0.030 0.032 0.928 0.005 0.043 0.044 0.930
cure-2 0.005 0.022 0.022 0.938 0.008 0.026 0.028 0.924 0.003 0.033 0.033 0.926
n=800
γ0 0.023 0.118 0.116 0.942 0.015 0.092 0.102 0.916 -0.031 0.128 0.122 0.930
γ1 -0.028 0.141 0.136 0.944 0.014 0.147 0.151 0.938 0.022 0.159 0.161 0.932
β1 0.003 0.082 0.092 0.922 0.001 0.122 0.116 0.938 0.004 0.137 0.132 0.944
β2 -0.003 0.048 0.052 0.918 -0.002 0.060 0.062 0.940 0.004 0.054 0.057 0.922
cure-1 0.002 0.015 0.014 0.942 0.005 0.018 0.018 0.916 0.005 0.026 0.026 0.930
cure-2 -0.001 0.014 0.015 0.940 0.006 0.020 0.020 0.924 0.007 0.023 0.023 0.934
Figure 2.3: Baseline Survival Probability Estimation for Weibull Data by Semipara-
metric MCPH+BM Model (800 Sample Size).
present the methods used to fit the data including the parametric MCPH+BM model
by using Weibull, Lognormal, Loglogistic baseline distributions and our proposed
semiparametric method. For the parametric methods, the diagonal estimation, where
the distribution is correctly specified, provides a good estimation with small biases,
small standard errors and good coverage probabilities. The proposed semiparametric
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Figure 2.4: Baseline Survival Probability Estimation for Lognormal Data by Semi-
parametric MCPH+BM Model (200 Sample Size).
Figure 2.5: Baseline Survival Probability Estimation for Lognormal Data by Semi-
parametric MCPH+BM Model (400 Sample Size).
MCPH+BM model performs well in parameters and cure fraction estimation for
different data distributions with small biases and the coverage probabilities close to
the nominal 95%. Therefore, the semiparametric method for MCPH+BM model
works well for different parametric assumptions.
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Figure 2.6: Baseline Survival Probability Estimation for Lognormal Data by Semi-
parametric MCPH+BM Model (800 Sample Size).
Figure 2.7: Baseline Survival Probability Estimation for Loglogistic Data by Semi-
parametric MCPH+BM Model (200 Sample Size).
2.5 Real Data Study
2.5.1 SEER Regional Female Breast Cancer
We applied the proposed semiparametric MCPH+BM model to the SEER Louisiana
regional female breast cancer data (Howlader et al., 2019), and compare its perfor-
mance to that under the standard MCPH model via semiparametric approach. The
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Figure 2.8: Baseline Survival Probability Estimation for Loglogistic Data by Semi-
parametric MCPH+BM Model (400 Sample Size).
Figure 2.9: Baseline Survival Probability Estimation for Loglogistic Data by Semi-
parametric MCPH+BM Model (800 Sample Size).
event of interest is the status of death or not. We fit the data with the covariates of
race and grade in both cure rate function and latency survival function such that
Spop(t|age, gender, race, grade) =S∗(t|age, gender)
{
π(race, grade)S0(t)exp[β(race,grade)]
+ [1− π(race, grade)]
}
,
where race = 1 for the white people and = 2 for the black people, and grade is a
measurement of how closely the tumor cells resemble normal breast cells with 1 to
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Figure 2.10: Predicted Net Survival Probability for the Simulated Data of 200 Sample
Size Weibull Distribution: dashed line and solid line represent the predicted survival
probabilities for treatment and control arms respectively.
Figure 2.11: Predicted Net Survival Probability for the Simulated Data of 200 Sam-
ple Size Lognormal Distribution: dashed line and solid line represent the predicted
survival probabilities for treatment and control arms respectively.
9 representing different degrees of differentiation. Similar to the simulation studies,
the background mortality distribution is approximated by the Weibull distribution
based on “2015 USA Life Table” with the matched sex and age. We also compare
the performance of the MCPH+BM model to that under the standard MCPH model
for the subgroup of age ≤ 70 and age > 70.
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Figure 2.12: Predicted Net Survival Probability for the Simulated Data of 200 Sam-
ple Size Loglogistic Distribution: dashed line and solid line represent the predicted
survival probabilities for treatment and control arms respectively.
Table 2.6: SEER Louisiana regional female breast cancer: parameters estimation in
the semiparametric MCPH+BM model and the semiparametric MCPH model, race
and grade are included in both the cure logistic link function and latency survival
function. Model I is to fit the whole data set with 6200 observations, Model II is
to fit the subgroup of age ≤ 70 with 4267 observations, and Model III is to fit the
subgroup of age > 70 with 1933 observations.
MCPH+BM MCPH
Par Est StErr CI Est StErr CI
Model I: whole data γ0 -1.140 0.111 (-1.358,-0.922) -0.140 0.132 (-0.399,0.119)
γ1 0.476 0.070 (0.339,0.613) 0.151 0.100 (-0.045,0.347)
γ2 0.081 0.016 (0.050,0.112) 0.039 0.021 (-0.002,0.080)
β1 0.382 0.039 (0.306,0.458) 0.219 0.068 (0.086,0.352)
β2 0.089 0.013 (0.064,0.114) 0.060 0.015 (0.031,0.089)
cure-W 0.605 0.020 (0.566,0.644) 0.468 - -
cure-B 0.487 0.012 (0.463,0.511) 0.431 - -
Model II: subgroup of age ≤ 70
γ0 -1.419 0.125 (-1.664,-1.174) -0.932 0.130 (-1.187,-0.678)
γ1 0.506 0.078 (0.353,0.659) 0.351 0.083 (0.188,0.514)
γ2 0.071 0.018 (0.036,0.106) 0.053 0.025 (0.004,0.102)
β1 0.113 0.067 (-0.018,0.244) 0.257 0.087 (0.086,0.428)
β2 0.051 0.027 (-0.002,0.104) 0.056 0.021 (0.015,0.097)
cure-W 0.669 0.020 (0.630,0.708) 0.604 - -
cure-B 0.549 0.012 (0.525,0.573) 0.518 - -
Model III: subgroup of age > 70
γ0 -0.831 0.217 (-1.26,-0.41) 0.954 0.294 (0.378,1.530)
γ1 0.461 0.149 (0.169,0.753) 0.273 0.254 (-0.225,0.771)
γ2 0.090 0.032 (0.027,0.153) 0.017 0.046 (-0.073,0.107)
β1 0.508 0.046 (0.418,0.598) 0.212 0.095 (0.026,0.398)
β2 0.038 0.015 (0.009,0.067) 0.074 0.020 (0.035,0.113)
cure-W 0.526 0.045 (0.438,0.614) 0.218 - -
cure-B 0.411 0.023 (0.366,0.456) 0.175 - -
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In Table 2.6, Model I shows the estimation for the whole SEER Louisiana regional
female breast cancer data set. The estimated cure rates are 60.46% and 48.73% for
white people and black people in the semiparametric MCPH+BM model, compared
to 46.84% and 43.11% in the standard MCPH model via semiparametric method. The
race and grade are both significant in the proposed MCPH+BM model, while they
are not significant in the cure function under the standard MCPH model. Model
II in Table 2.6 shows that for the subgroup of age ≤ 70, the estimated cure rates
are 66.90% and 54.93% for white people and black in the MCPH+BM model, and
are 60.41% and 51.78% in the standard MCPH model. Both race and grade have
significant impact on the cure fraction in the proposed MCPH+BM model. Model III
indicates that for the subgroup of age > 70, the estimated cure rates are 52.56% and
41.12%, which are much higher than the cure fraction estimation 21.81% and 17.51%
under the standard MCPH model. Figure 2.13 shows the predicted observed survival
probability under the standard MCPH model and predicted net survival probability
under the proposed MCPH+BM model by race, which indicate higher cure fraction
estimation from the proposed semiparametric MCPH+BM model compared to the
standard MCPH model, and it is consistent with the estimation in Table 2.6. The
similar conclusions are also found in the subset of age > 70 and ≤ 70 shown in Figure
2.14 and 2.15.
2.5.2 Software
We develop a R package named “psmcure” based on the proposed MCPH+BMmodel,
which can be downloaded from the Github repository
install_github("gygygy1989/psmcure"). The main function is bmcure() with
arguments including formula which incidates the covariates in the latency survival
function, cureform includes the covariates in cure link function, link is the type of
link function which can be “logistic”, “probit”, and “cloglog”, data is the dataset
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Figure 2.13: The MCPH+BM model predicts the net survival probability by race,
and the MCPH model predicts the observed (net) survival probability by race.
Figure 2.14: Predicted net survival under the MCPH+BM model and the MCPH
model for the subgroup of Age > 70 in the SEER regional female breast cancer.
used, table 1 and table 2 are the USA Life Table for female and male, na.action
is the action to deal with missing data, method can be either “semiparametric”,
“flexible” or “parametric”, and dis for distribution must be specified when the method
is “parametric”. A pseudo real data was generated and fitted shown in Figure 2.16.
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Figure 2.15: Predicted net survival under the MCPH+BM model and the
MCPH+BM model for the subgroup of Age ≤ 70 in the SEER regional female breast
cancer.
>fit<- bmcure(formula=Surv(Time,Status)∼ race+grade,
cureform=∼ race+grade,link="logistic",data=data,table1=table1,
table2=table2,na.action=na.omit,method="semiparametric",dis=NULL)
Figure 2.16: Pseudo Data Estimation Output by the R Package “psmcur”
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2.6 Conclusions and Discussions
“Cure” in a population level is defined as that the mortality risk of “cured patients”
will return to the similar mortality risk as their counterpart in the general population
(De Angelis et al., 1999). Many survival studies show that the MCPH+BM model
is a useful tool in analyzing such data and provides insight on population-based sur-
vival study. The proposed semiparametric method in the MCPH+BM model is more
appealing in practice due to its great modeling flexibility and computation efficiency.
The simulation studies show that the semiparametric method in the MCPH+BM
model via EM algorithm is comparable to the fully parametric method when the
parametric baseline function is correctly specified and also comparable to the flexible
method when the best number of knots is selected by information criterion such as
AIC. Moreover, the computation of EM algorithm with perturbation variance esti-
mation is efficient compared to bootstrap method. The real data analysis illustrates
the usage of proposed semiparametric MCPH+BM model to the SEER data, and it
may provide more accurate estimation of cure fraction in population level.
The proposed semiparametric method is expected to promote the application
of the MCPH+BM model in practice. The MCPH+BM model works well in the
situations when the cause of death is unknown or not recorded, so that death not
only contributes to the disease under study, but also results from the background
mortality of the whole population. Specifically, when there is a plateau observed from
Kaplan-Meier curve and the death is a disease-related death, the standard MCPH
model is suggested. In the case that the event at the last survival time is death
indicating no plateau in Kaplan-Meier curve, there is no visual evidence suggesting
the cure fraction and the advice from domain experts may help to choose the best
model. If the death is all-cause death and the cause of death is unknown, the proposed
MCPH+BM model is recommended to estimate cure rate in population level. Note,
the appropriate background mortality should be used in practice. We used the “2015
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USA Life Table” since the SEER data is population representative, while the samples
in the clinical trial may not be a random sample from the whole population and the
population level mortality are not applicable. In terms of variable selection in the
MCPH+BM model, AIC can not be used in semiparametric method directly, but a
forward or backward selection based on the Wald test combining with suggestions
from domain experts can be used to select variables in cure link function and latency
survival function.
Currently, there are efforts working toward adjusting the post-cancer mortality
from general population background mortality through drug reimbursement, and the
adjusted background mortality may be applied in the future.
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Chapter 3
Semiparametric Estimation in the
Population-level Promotion Time Cure Model
Abstract
Similar to the mixture cure proportional hazards model with background mortality
(MCPH+BM) model, another widely used cure model, i.e., the promotion time cure
model also can be extended to the population-level cancer study. The “cured” in
population level is defined as when the mortality rate of the individuals in diseased
group returns to the same level as that expected in the general population, where the
population level mortality is presented by the mortality table of the United States.
We develop a promotion time cure model with background mortality (PCPH+BM)
model and propose an EM algorithm in semiparametric regression. Simulation stud-
ies and real data analysis show that the proposed semiparametric approach provides
good performance in estimation of parameters, cure fraction and survival functions
in population-level cancer study, and it also largely avoid the problem of misspecifi-
cation.
3.1 Introduction
The cure models have been proposed and studied, considering a proportion of sub-
jects will never experience the event of interest in the time-to-event data. Boag
(1949) proposed the classic two-component mixture cure model, which treats the
whole population as a mixture of cured patients and uncured patients. Specifically,
48
the two-component mixture cure model is a mixture of a cure fraction and the la-
tency survival function for the uncured patients, which is more advantageous than
standard survival models such as the Cox PH model when a plateau occurs on the
tail of survival curves. This model has been extensively discussed by many authors,
including Farewell (1982); Gray and Tsiatis (1989); Kuk and Chen (1992); Sposto,
Sather, and Baker (1992); Taylor (1995); and Stangl and Greenhouse (1998) among
others.
From the perspective of both frequentist and Bayesian, the mixture cure model
has some limits pointed out by Chen, Ibrahim, and Sinha (1999) and Ibrahim, Chen,
and Sinha (2001). Firstly, it does not have the proportional hazards structure in the
presence of covariates, since many asymptotic and computational results require a
proportional hazards structure for survival models. Second, the mixture cure model
in the equation (1.3) yields improper posterior distributions for many noninforma-
tive improper priors including the uniform prior for the regression coefficients when
covaraites are included in the link function. This is a main problem in Bayesian
inference. Yakovlev et al. (1993) proposed a new formulation for the standard two-
component mixture cure model to study the promotion time of cancer metastases
(1.4). The non-mixture cure model or promotion time cure model (PTCM) has been
studied by Andrei and Asselain (1996); Tsodikov (1998); Ibrahim, Chen, and Sinha
(2001) and so on. The PTCM has its advantages such that it can inherit the pro-
portional hazards structure for the whole population which makes the interpretation
of regression parameters more acceptable. In addition, the model provides a bio-
logical derivation which involves the number of tumor cells that have potential to
metastasize. Zeng, Yin, and Ibrahim (2006) proposed the nonparametric maximum
likelihood estimator (NPMLE) for the PTCM. Ibrahim, Chen, and Sinha (2014) dis-
cussed Bayesian approaches to fit the PTCM. Chen and Du (2018) proposed the
estimation with smoothing splines in penalized profile likelihood.
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Similar to in Chapter 2, inspired by the relative survival that observed survival
probability is actually the product of net survival probability and expected survival
probability, we also incorporate the background mortality into the PTCM and explore
the cure fraction estimation in a population level. The PTCM has been extended to
incorporate background mortality rates in parametric regression models by Lambert
et al. (2006). They (Lambert, 2007) also developed the STATA commands. Anders-
son et al. (2011) developed a flexible parametric survival model which is a special case
of the PTCM. The population-level PTCM incorporating background mortality via
semiparametric method has not been studied yet. The purpose of this chapter is to
fill the gap in the study of semiparametric estimation approach in the promotion time
cure model with background mortality. The rest of the paper is organized as follows.
Section 3.2 illustrates the proposed model with background mortality (PTCM+BM).
The semiparametric estimation methods and variance estimation are described in
Section 3.3 based on the EM algorithm. Section 3.4 outlines the simulation studies
and Section 3.5 applies the proposed method to the real data. Section 3.6 provides
some discussions.
3.2 Promotion Time Cure Model with Background Mortality
The standard promotion time cure model (PTCM) has been discussed in Chapter
1. By incorporating background mortality, the promotion time cure model with
background mortality (PTCM+BM) has the overall survival function for the subject
i = 1, . . . , n, expressed as
Spop(t|zi,xi) = S∗i (t) exp{−π(zi)F (t|xi)}
and the corresponding population-level hazard function is
hpop(t|zi,xi) = h∗i (t) + π(zi)f(t|xi),
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where S∗i (t) is the background survival probability and h∗i (t) is the background mor-
tality rate at time t for the subject i = 1, . . . , n. Note that π(zi) is a link function
for the subject i with respect to the covariate zi. For the latency part, F (t|xi) is
the latency cumulative distribution function with respect to the covariate xi for the
subject i, and f(t|xi) is the corresponding probability density function. Considering
the proportional hazards structure for the latency survival function, the PTCM+BM
becomes the promotion time cure proportional hazards model with background mor-
tality (PTPH+BM).
Suppose there are n iid right-censored observations,
Oi = {yi = min(ti, Ci), zi,xi), δi = I(ti ≤ Ci); i = 1, . . . , n} where δi is the indicator
function with 1 for death and 0 for right censoring, zi is a vector of covariates which
have potential effects on the link function, and xi is a vector of covariates for the
latency survival function. We assume that the right-censored time Ci is independent
provided that it is random and non-informative such that the distribution of survival
times provides no information about the distribution of censoring times. Let the un-
known parameters denoted by Θ = {γ,β, h0(t), S0(t)}, then the observed likelihood
function is given by
Lobs(Θ; O) =
n∏
i=1
{h∗(yi) + π(zi)f(yi|xi)}δiS∗(yi) exp{−π(zi)F (yi|xi)}
=
n∏
i=1
{h∗(yi) + π(zi)h0(yi) exp (βᵀxi)S0(yi)exp (β
ᵀxi)}δiS∗(yi)
exp
[
− π(zi){1− S0(yi)exp (β
ᵀxi)}
]
and the logarithm observed likelihood function is
Lobs(Θ; O) =
n∑
i=1
[
δi log{h∗(yi) + π(zi)h0(yi) exp (βᵀxi)S0(yi)exp (β
ᵀxi)}
+ logS∗(yi)− π(zi){1− S0(yi)exp (β
ᵀxi)}
]
.
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3.3 EM Algorithm
The latent variables Ni is the number of metastasis-competent tumour cells for the
subject i, which has a Poisson distribution with mean of π(zi). Similar to the equation
(1.5), the survival function in the PCPH+BM model can be further derived as
Spop(t|zi,xi) = S∗(t)
[
exp{−π(zi)}+
∞∑
k=1
{1− F (t|xi)}k
π(zi)k exp{−π(zi)}
k!
]
= S∗(t)
[
exp{−π(zi)}+
∞∑
k=1
{S0(t)exp (β
ᵀxi)}kπ(zi)
k exp{−π(zi)}
k!
]
.
The promotion time for the kth (k = 1, . . . , Ni) tumour cell is denoted as T̃k, which
is the time for the kth metastasis-competent tumour cell to produce a detectable
tumour mass. The survival function for the kth tumour cell can be written as
{1− F (t|xi)}k
π(zi)k exp{−π(zi)}
k! ,
and its corresponding probability density function is derived as
k{1− F (t|xi)}k−1f(ti|xi)
π(zi)k exp{−π(zi)}
k! .
Thus, its corresponding hazard function is kf(t|xi)/{1− F (t|xi)}.
The complete likelihood function in the PCPH+BM with the latent variables N
is
Lc(Θ; O,N) =
n∏
i=1
{h∗(yi) +Nih0(yi) exp (βᵀxi)}δiS∗(yi){S0(yi)exp (β
ᵀxi)}Ni
π(zi)Ni exp{−π(zi)}
Ni!
,
(3.1)
where we suppose the link function π(zi) takes the exponential form of π(zi) =
exp(γᵀzi).
3.3.1 E-step
In EM algorithm, E-step is to take expectation of the complete likelihood function
with respect to Ni given the observed data O. When δi = 1, Ni = 0, 1, 2, . . . ,∞
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in the PCPH+BM, which is different from the case when the background mortality
is ignored and a subject dies only from the cancer under study, then Ni takes on
values of 1, . . . ,∞. The conditional complete likelihood function in the PCPH+BM,
therefore becomes more complex. We will derive the algorithm in E-step in detail on
two cases separately (δi = 1 and δi = 0).
The equation (3.1) conditional on δi = 1 is written as
Lc(Θ; O,N|δi = 1) =
n∏
i=1
(
h∗(yi)S∗(yi) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
]
× {S0(yi)
exp (βᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
+ S∗(yi)Nih0(yi) exp (βᵀxi) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
]
× {S0(yi)
exp (βᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
)
.
(3.2)
Taking integral of the equation (3.2) over the latent variable N, the marginal complete
likelihood function given δi = 1 is
Lc(Θ; O|δi = 1) =
n∏
i=1
( ∞∑
Ni=0
{S0(yi)exp (β
ᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
h∗(yi)
× S∗(yi) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
]
+
∞∑
Ni=0
Ni
{S0(yi)exp (β
ᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
× h0(yi) exp (βᵀxi)S∗(ti) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
])
=
n∏
i=1
(
h∗(yi)S∗(yi) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
]
+ S0(yi)exp (β
ᵀxi)π(zi)h0(ti) exp (βᵀxi)S∗(yi)
× exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
])
.
To simplify expressions in the following algorithm, let Ai = h∗(yi)S∗(yi) exp
[
−
{1−S0(yi)exp (β
ᵀxi)}π(zi)
]
and Bi = S0(yi)exp (β
ᵀxi)π(zi)h0(yi) exp (βᵀxi)S∗(yi) exp
[
−
{1−S0(yi)exp (β
ᵀxi)}π(zi)
]
for the subject i. The conditional likelihood function of N
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given the parameters Θ, the observed data O and δi = 1 is
Lc(N|Θ,O; δi = 1) =
n∏
i=1
( Ai
Ai +Bi
{S0(yi)exp (β
ᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
+ Bi(Ai +Bi)S0(yi)exp (βᵀxi)π(zi)
× {S0(yi)
exp (βᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}Ni
Ni!
)
,
and then the expectation of Ni given Θ, O and δi = 1 is
E(Ni|Θ,O; δi = 1) =
Ai
Ai +Bi
S0(yi)exp (β
ᵀxi)π(zi) +
Bi
Ai +Bi
{1 + S0(yi)exp (β
ᵀxi)π(zi)},
(3.3)
which is a weighted mean of S0(yi)exp (β
ᵀxi)π(zi) and 1 + S0(yi)exp (β
ᵀxi)π(zi).
When δi = 0, Ni = 0, 1, 2, . . . ,∞, the equation (3.1) given δi = 0 is
Lc(Θ; O,N|δi = 0) =
n∏
i=1
S∗(yi) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
]
× {S0(yi)
exp (βᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
and the marginal complete likelihood function over N given δi = 0 is
Lc(Θ; O|δi = 0) = S∗(yi) exp
[
− {1− S0(yi)exp (β
ᵀxi)}π(zi)
]
.
The conditional likelihood function of N given Θ, O and δi = 0 is
Lc(N|Θ,O; δi = 0) =
{S0(yi)exp (β
ᵀxi)π(zi)}Ni exp{−S0(yi)exp (β
ᵀxi)π(zi)}
Ni!
,
and the expectation of Ni given Θ, O and δi = 0 is
E(Ni|Θ,O; δi = 0) = S0(yi)exp (β
ᵀxi)π(zi). (3.4)
In summary, the equation (3.3) and (3.4) can be written in one single formula as
ω1i =E(Ni|Θ,O)
=δi
[ Ai
Ai +Bi
S0(yi)exp (β
ᵀxi)π(zi) +
Bi
Ai +Bi
{1 + S0(yi)exp (β
ᵀxi)π(zi)}
]
+ (1− δi)S0(yi)exp (β
ᵀxi)π(zi).
(3.5)
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The expectation of the logarithm complete likelihood function is expressed as
Q(N; Θ,O) =
n∑
i=1
(
δiE
[
log{h∗(yi) +Nih0(yi) exp (βᵀxi)}
]
+ E(Ni) log{S0(yi)exp (β
ᵀxi)}+
n∑
i=1
E(Ni) log{π(zi)]− π(zi)
)
=
n∑
i=1
δiω2i + ω1i log[S0(yi)exp (β
ᵀxi)}+ ω1i log{π(zi)} − π(zi),
(3.6)
where E
[
log{h∗(yi) + Nih0(yi) exp (βᵀxi)}
]
is denoted as ω2i for simplification in
expression.
The equation (3.6) can be further written as the summation of two separate
functions
Q1(γ; z,ω1) =
n∑
i=1
ω1i log{π(zi)} − π(zi) (3.7)
and
Q2{β, h0(y), S0(y); x,ω2} =
n∑
i=1
δiω2i + ω1i exp (βᵀxi) log{S0(yi)}, (3.8)
where function (3.7) only involves the parameter γ in cure function π(zi) = exp(γᵀzi)
and function (3.8) involves baseline functions and the parameter β.
3.3.2 M-step
In M-step, we maximize the equation (3.7) and (3.8) via Newton-Raphson method
using “optim” function in R to update γ, baseline functions and β, respectively, which
improves computation efficiency. The background mortality h∗(t) in the expectation
term ω2i are sex and age matched constant pieces in the calculation.
For baseline estimation, t1 < t2 < · · · < tp are the distinct ordered uncensored
failure times, and let λ0j (j = 1, · · · , p) be the jump size at each death point. Take
first derivative of the equation (3.8) and set it to 0, we have
∂Q2{β, h0(t), S0(t)}
∂λ0j
= δj
∂E log{h∗(tj) +Njλ0j exp (βᵀxj)}
∂λ0j
−
p∑
l=j
ω1l exp (βᵀxl)
= δjE{
Nj exp (βᵀxj)
h∗(tj) +Njλ0j exp (βᵀxj)
} −
p∑
l=j
ω1l exp (βᵀxl) = 0.
(3.9)
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Note that the expectation term in the equation (3.9) can be estimated by iteration
until convergence such that
E{ Nj exp (β
ᵀxj)
h∗(tj) +Njλ0j exp (βᵀxj)
} = E{ 1
λ0j
− h
∗(tj)/λ0j
h∗(tj) +Njλ0j exp (βᵀxj)
}
= 1
λ0j
− h
∗(tj)
λ0j
E{ 1
h∗(tj) +Njλ0j exp (βᵀxj)
}.
(3.10)
Update λm0j in the m iteration by plugging the equation (3.10) into equation (3.9),
the converged λm0j would be the value when the difference between λm0j and λm−10j is
less than a small value such as 1e-7, which is written as
λm0j =
δj
[
1− h∗(tj)E{ 1h∗(tj)+Njλm−10j exp (βᵀxj)}
]
∑p
l=j ω1l exp (βᵀxl)
.
Thus, the baseline hazard function and baseline survival function for the subject i
are
hm0 (yi;β,xi, ω1i) =
δi
[
1− h∗(yi)E{ 1h∗(yi)+Niλm−10 (yi) exp (βᵀxi)}
]
∑n
l:yl≤yi ω1l exp (βᵀxl)
, (3.11)
and
Sm0 (yi;β,xi, ω1i, ω3i) = exp{−
∑
l:yl≤yi
λm0 (yl)}. (3.12)
The following conditional expectation terms for the subject i are also needed in
the M-step algorithm,
ω2i = E
[
log{h∗(yi) +Nih0(yi) exp (βᵀxi)}|Θ,O
]
=
∞∑
k=0
(
log{h∗(yi) + kh0(yi) exp (βᵀxi)} × Lc(k|Θ,O)
)
= δi
∞∑
k=0
(
log{h∗(yi) + kh0(yi) exp (βᵀxi)} × Lc(k|Θ,O; δi = 1)
)
+ (1− δi)
∞∑
j=0
(
log{h∗(yi) + kh0(yi) exp (βᵀxi)} × Lc(k|Θ,O; δi = 0)
)
,
(3.13)
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and
ω3i = E{
1
h∗(yi) +Nih0(yi) exp (βᵀxi)
|Θ,O}
=
∞∑
k=0
( 1
h∗(yi) + kh0(yi) exp (βᵀxi)
× Lc(k|Θ,O)
)
= δi
∞∑
k=0
( 1
h∗(yi) + kh0(yi) exp (βᵀxi)
× Lc(k|Θ,O; δi = 1)
)
+ (1− δi)
∞∑
k=0
( 1
h∗(yi) + kh0(yi) exp (βᵀxi)
× Lc(k|Θ,O; δi = 0)
)
.
(3.14)
The EM algorithm for estimating the parameters Θ = {γ,β, h0(y), S0(y)} is
summarized as follows,
Step 0: Set initial values ω01i,ω02i and ω03i as the subject censoring indicators δi, (i =
1, 2, · · · , n), the initial values γ0 are estimated from the logistic regression
with ω01 as the response variable and z as the covariates, and the initial
values β0 are estimated from the cox proportional hazards model with x as
the covariates;
Step 1: In (d+1) iteration, update γ(d+1) via maximizing (3.7) using “optim”;
Step 2: Update β(d+1) via maximizing equation (3.8) using “optim”, where the base-
line hazard and survival functions are replaced by (3.11) and (3.12);
Step 3: Update h(d+1)0 (yi;β(d+1),xi, ω
(d)
1i , ω
(d)
3i ) and S
(d+1)
0 (yi;β(d+1),xi, ω
(d)
1i , ω
(d)
3i ) us-
ing equation (3.11) and (3.12); then update ω(d+1)1i , ω
(d+1)
2i and ω
(d+1)
3i by the
equation (3.5),(3.13) and (3.14), respectively;
Step 4: Iterate steps 1-3 till convergence when the difference of two successive itera-
tions is less than 1e-7.
For variance estimation, the resampling method proposed by Jin, Ying, and Wei
(2001) is adapted. We introduce a random variable V which follows the distribution
Gamma(1, 1), and the likelihood functions in the equations (3.7) and (3.8) become,
V1(γ; z, ω) =
n∑
i=1
Vi
[
ω1i log{π(zi)} − π(zi)
]
, (3.15)
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and
V2{β, h0(y), S0(y); x, ω} =
n∑
i=1
Vi
[
δiω2i + ω1i exp (βᵀxi) log{S0(yi)}
]
. (3.16)
The maximization of equations (3.15) and (3.16) can be implemented in the same
way as in the proposed EM algorithm to find the estimators Θ̃’s, and the resampling
procedure is started with M = 500 samples of Vi, as recommended in the Jin, Ying,
and Wei (2001). The variance estimation of parameters is then the empirical variance
of the M estimators Θ̃’s.
3.4 Simulation Studies
Simulation studies are conducted to evaluate the performance of the proposed semi-
parametric estimation method in the PCPH+BM model. We compare the perfor-
mance of our proposed model to fully parametric methods. The fully parametric
method is to model the baseline hazard rate and baseline survival probability with
the corresponding parametric distributions of Weibull, Lognormal and Loglogistic via
the EM algorithm.
Similar to in Chapter 2, we generate covariates z from a Bernoulli distribution with
probability 0.5 with 0 and 1 for the group indicator. Setting γ to (log(2),−1) gives
the cure rate about 33% and 58% for two groups for illustration. Uncured indicators
are generated from a Bernoulli distribution with the probability of uncured rate.
The covariate of “age” is generated from a normal distribution with mean of 70 and
standard deviation of 5, and “sex” from a Bernoulli distribution with the probability
of 0.5.
For a patient being cured, the survival time is generated from the background
mortality distribution. The background mortality is matched based on the estimated
Weibull distribution approximated using “2015 USA Life Table” (Arias and Xu, 2018).
The “2015 USA Life Table” has survival probability for male and female at the age
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of 0 to 110. For each sex and age combination, we approximate the life table via a
Weibull distribution and those estimated parameters of Weibull distribution are used
as the background mortality parameters. Then we match the sex and age in the data
set with those in the background mortality table, and use the parameters to generate
survival times from the background mortality.
For the uncured patients who may die from the disease under study or some
other causes, the survival time is the minimum value generated from the background
mortality distribution and the latency proportional hazards model. In the latency
proportional hazards model, we include the covariates of group and sex, and set their
coefficients β to (1,−1). Several baseline survival functions, Weibull distribution
with shape=0 and scale=1, Lognormal distribution with mean=0 and standard de-
viation=1, and Loglogistic distribution with shape=2 and scale=1 are considered in
the proportional hazards model to simulate data set. The censoring time is generated
from an exponential distribution exp (c) where c controls the censoring rate at about
50%.
A small (n=200), medium (n=400) and large (n=800) sample size with 500 repli-
cates are considered for each simulation setup. A sensitivity analysis of 800 sample
size is further done to illustrate the problem of misspecification in the fully paramet-
ric method. The simulation results include bias which are calculated as the average
of differences between point estimators and their true values, average estimated stan-
dard error (StErr), empirical standard deviation (StDev), CPs which are the average
coverage probabilities of the 95% confidence intervals.
Table 3.1-3.3 show that the proposed semiparametric PCPH+BM model estimate
parameters and cure fraction well and the performance is comparable to the fully
parametric methods. The biases for all parameters and cure fraction are small and
the corresponding CPs are close to the nominal 95%. The estimated standard errors
for paratemers are similar in magnitude for different data distributions, and become
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Table 3.1: Summary Statistics for Weibull Data: by proposed semiparametric method
and parametric method with Weibull baseline function.
Semiparametric Method Parametric Method
Par Bias StErr StDev CP Bias StErr StDev CP
n=200 b0 0.031 0.205 0.170 0.972 0.009 0.140 0.149 0.922
b1 -0.021 0.184 0.184 0.954 -0.017 0.194 0.204 0.922
β1 0.022 0.239 0.235 0.940 0.023 0.257 0.251 0.934
β2 -0.011 0.134 0.138 0.948 -0.029 0.148 0.148 0.938
shape - - - - 0.016 0.062 0.062 0.938
scale - - - - 0.052 0.344 0.351 0.900
cure-1 -0.005 0.058 0.056 0.945 0.001 0.057 0.058 0.924
cure-2 -0.004 0.047 0.045 0.940 0.001 0.038 0.039 0.922
n=400 b0 0.024 0.147 0.118 0.965 0.020 0.097 0.101 0.942
b1 -0.024 0.127 0.130 0.944 -0.010 0.134 0.133 0.924
β1 0.017 0.175 0.170 0.952 0.011 0.177 0.176 0.928
β2 -0.012 0.098 0.100 0.936 -0.014 0.100 0.098 0.936
shape - - - - 0.008 0.042 0.041 0.930
scale - - - - 0.045 0.233 0.232 0.936
cure-1 -0.001 0.041 0.039 0.960 -0.004 0.039 0.039 0.940
cure-2 -0.004 0.033 0.034 0.938 -0.004 0.026 0.027 0.930
n=800 b0 0.015 0.102 0.083 0.962 0.008 0.070 0.069 0.942
b1 -0.022 0.090 0.092 0.936 -0.006 0.098 0.099 0.952
β1 0.014 0.128 0.126 0.942 0.018 0.128 0.117 0.968
β2 -0.017 0.062 0.066 0.960 -0.011 0.072 0.067 0.964
shape - - - - 0.007 0.030 0.028 0.958
scale - - - - 0.012 0.162 0.150 0.960
cure-1 0.002 0.028 0.026 0.964 -0.001 0.029 0.029 0.942
cure-2 -0.003 0.025 0.023 0.942 -0.001 0.020 0.019 0.946
smaller when small size increases. Thus, the accuracy of parameters estimation gets
better with the increase of sample size. The sensitivity analysis in Table 3.4 uses
sample size of 800 and indicates that the proposed semiparametric method performs
better than fully parameter methods. The columns show the true data distributions
(Weibull, Lognormal and Loglogistic), while rows present the methods used to fit the
data including the parametric PCPH+BM model by using Weibull, Lognormal and
Loglogistic baseline distributions, and also the proposed semiparametric method. For
the parametric estimation methods, the diagonal estimation provides good estimation
with small biases, small standard errors and good coverage probabilities, since the
data distribution is correctly specified. The proposed semiparametric PCPH+BM
model performs well in estimating all parameters and cure fraction for different data
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Table 3.2: Summary Statistics for Lognormal Data: by proposed semiparametric
method and parametric method with Lognormal baseline function.
Semiparametric Method Parametric Method
Par Bias StErr StDev CP Bias StErr StDev CP
n=200 b0 0.006 0.274 0.229 0.962 0.008 0.144 0.152 0.928
b1 -0.002 0.175 0.182 0.938 -0.003 0.200 0.211 0.930
β1 0.013 0.282 0.268 0.942 0.012 0.268 0.262 0.948
β2 0.032 0.136 0.148 0.925 -0.018 0.154 0.155 0.928
shape - - - - 0.011 0.195 0.195 0.936
scale - - - - -0.009 0.085 0.083 0.924
cure-1 -0.003 0.057 0.055 0.960 -0.003 0.058 0.059 0.930
cure-2 0.004 0.045 0.049 0.936 0.001 0.039 0.040 0.930
n=400 b0 -0.001 0.174 0.150 0.966 0.014 0.101 0.104 0.941
b1 -0.003 0.120 0.127 0.932 -0.005 0.141 0.146 0.935
β1 0.005 0.201 0.194 0.958 0.002 0.186 0.177 0.963
β2 -0.015 0.092 0.104 0.944 -0.012 0.106 0.107 0.935
shape - - - - 0.009 0.137 0.135 0.949
scale - - - - -0.002 0.059 0.057 0.961
cure-1 0.001 0.042 0.040 0.962 -0.004 0.043 0.044 0.940
cure-2 0.003 0.035 0.037 0.938 -0.002 0.028 0.028 0.936
n=800 b0 0.003 0.121 0.103 0.962 0.009 0.071 0.071 0.942
b1 -0.017 0.085 0.089 0.934 -0.008 0.100 0.096 0.966
β1 0.022 0.142 0.131 0.958 0.017 0.131 0.134 0.934
β2 -0.007 0.062 0.069 0.940 -0.007 0.074 0.076 0.942
shape - - - - 0.009 0.096 0.098 0.930
scale - - - - -0.003 0.041 0.041 0.952
cure-1 0.005 0.029 0.027 0.958 -0.000 0.029 0.029 0.940
cure-2 0.001 0.026 0.027 0.932 -0.002 0.020 0.019 0.952
distributions. Therefore, the semiparametric method for PCPH+BM model would
largely avoid the misspecification problem in fully parametric methods.
3.5 Breast Cancer Data Analysis
We applied the proposed semiparametric PCPH+BM model to the SEER Louisiana
regional female breast cancer data described in Chapter 1.2 (Howlader et al., 2019)
and compare its performance to the standard PCPHmodel via semiparametric method.
We fit the data with the covariates of race and grade in both the link function and
the latency survival function such that
Spop(t|age,sex,race,grade) = S∗(t|age,sex) exp{−π(race,grade)F (t|race,grade)}.
Similar to the simulation studies, the background mortality distribution is ap-
proximated by the Weibull distribution based on “2015 USA Life Table” with the
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Table 3.3: Summary Statistics for Loglogistic Data: by proposed semiparametric
method and parametric method with Loglogistic baseline function.
Semiparametric Method Parametric Method
Par Bias StErr StDev CP Bias StErr StDev CP
n=200 b0 -0.004 0.187 0.189 0.956 0.012 0.141 0.143 0.948
b1 0.011 0.180 0.173 0.942 -0.021 0.203 0.197 0.954
β1 -0.023 0.260 0.272 0.932 0.031 0.266 0.247 0.968
β2 0.012 0.153 0.142 0.930 -0.022 0.157 0.149 0.956
shape - - - - 0.056 0.179 0.175 0.944
scale - - - - 0.013 0.146 0.143 0.960
cure-1 -0.004 0.053 0.054 0.952 0.002 0.057 0.059 0.946
cure-2 0.006 0.047 0.049 0.940 -0.001 0.036 0.037 0.950
n=400 b0 -0.004 0.151 0.135 0.942 -0.002 0.098 0.095 0.956
b1 -0.001 0.138 0.125 0.928 -0.003 0.142 0.139 0.960
β1 0.002 0.176 0.185 0.932 0.010 0.185 0.176 0.962
β2 -0.002 0.115 0.103 0.942 0.000 0.107 0.109 0.950
shape - - - - 0.009 0.120 0.113 0.964
scale - - - - 0.007 0.103 0.102 0.958
cure-1 0.001 0.042 0.039 0.948 0.001 0.040 0.040 0.954
cure-2 0.004 0.036 0.035 0.932 0.002 0.025 0.026 0.952
n=800 b0 0.012 0.124 0.100 0.932 0.009 0.069 0.072 0.936
b1 -0.003 0.011 0.096 0.928 -0.007 0.100 0.100 0.948
β1 0.007 0.118 0.130 0.930 0.007 0.129 0.126 0.964
β2 -0.011 0.071 0.066 0.958 -0.003 0.074 0.074 0.954
shape - - - - 0.010 0.084 0.084 0.960
scale - - - - 0.007 0.072 0.072 0.948
cure-1 0.005 0.030 0.027 0.936 -0.001 0.029 0.029 0.936
cure-2 0.003 0.026 0.025 0.930 -0.002 0.018 0.019 0.942
matched sex and age. We also compare the performance of PCPH+BM model to
that of PCPH model for the subgroup of age > 70 and ≤ 70.
In Table 3.5, first part shows the estimation for the whole SEER Louisiana regional
female breast cancer data set. The estimated cure rates are 62.3% and 45.6% for the
white people and the black people in the semiparametric PCPH+BMmodel compared
to 47.0% and 42.9% in the standard PCPH model via semiparametric method. The
second part in Table 3.5 shows that for the subgroup of age ≤ 70, the estimated cure
rates are 69.1% and 54.2% for the white and black people in the PCPH+BM model,
and are 60.6% and 51.6% in the PCPH model. For the subgroup of age> 70, the
estimated cure rates are 55.1% and 34.4% for the white and black people under the
semiparametric PCPH+BM model, while the cure rates are estimated to be 22.1%
and 17.4% under the semiparametric PCPH model. Parameters estimation are all
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Table 3.4: Sensitivity Analysis for 800 Sample Size: rows represent parametric meth-
ods and semiparametric method, and columns are the Weibull, Lognormal and Loglo-
gistic data.
Weibull Lognormal Loglogistic
Par Bias SE SD-Est CP Bias SE SD-Est CP Bias SE SD-Est CP
Weibull b0 0.008 0.070 0.069 0.942 -0.092 0.055 0.070 0.592 -0.072 0.056 0.069 0.660
b1 -0.006 0.098 0.099 0.952 -0.002 0.081 0.103 0.734 0.006 0.081 0.102 0.726
β1 0.018 0.128 0.117 0.968 0.025 0.088 0.147 0.670 -0.012 0.088 0.132 0.680
β2 -0.011 0.072 0.067 0.964 -0.000 0.054 0.080 0.710 0.000 0.053 0.075 0.720
shape 0.007 0.030 0.028 0.958 1.651 0.030 0.065 0.000 -0.250 0.032 0.073 0.010
scale 0.012 0.162 0.150 0.960 0.143 0.037 0.104 0.240 0.186 0.035 0.092 0.102
cure-1 -0.001 0.029 0.029 0.942 0.032 0.024 0.029 0.586 0.023 0.022 0.029 0.584
cure-2 -0.001 0.020 0.019 0.946 0.027 0.018 0.021 0.602 0.021 0.012 0.020 0.648
Lognormal b0 0.139 0.077 0.076 0.556 0.009 0.071 0.071 0.942 0.037 0.072 0.074 0.918
b1 0.003 0.100 0.100 0.946 -0.008 0.100 0.096 0.966 0.006 0.100 0.099 0.942
β1 -0.003 0.142 0.116 0.974 0.017 0.131 0.134 0.934 0.005 0.139 0.116 0.990
β2 0.062 0.077 0.066 0.900 -0.007 0.074 0.076 0.942 0.041 0.077 0.071 0.940
shape -0.496 0.268 0.232 0.522 0.009 0.096 0.098 0.930 -1.840 0.101 0.092 0.000
scale 1.598 0.094 0.130 0.000 -0.003 0.041 0.041 0.952 0.024 0.037 0.049 0.816
cure-1 -0.051 0.032 0.032 0.550 -0.000 0.029 0.029 0.940 -0.016 0.027 0.029 0.920
cure-2 -0.034 0.015 0.018 0.620 -0.002 0.020 0.019 0.952 -0.009 0.018 0.019 0.922
Loglogistic b0 0.087 0.072 0.073 0.804 -0.033 0.070 0.069 0.910 0.009 0.069 0.072 0.936
b1 -0.008 0.098 0.097 0.960 -0.002 0.100 0.101 0.942 -0.007 0.100 0.100 0.948
β1 0.047 0.131 0.116 0.964 -0.026 0.126 0.140 0.906 0.007 0.129 0.126 0.964
β2 -0.006 0.074 0.068 0.962 -0.020 0.074 0.079 0.934 -0.003 0.074 0.074 0.954
shape 0.074 0.034 0.033 0.444 1.952 0.089 0.078 0.000 0.010 0.084 0.084 0.960
scale -0.188 0.151 0.132 0.708 -0.111 0.065 0.073 0.520 0.007 0.072 0.072 0.948
cure-1 -0.028 0.026 0.028 0.808 0.012 0.028 0.028 0.912 -0.001 0.029 0.029 0.936
cure-2 -0.022 0.020 0.018 0.882 0.010 0.019 0.019 0.930 -0.002 0.018 0.019 0.942
Semi
b0 0.015 0.102 0.083 0.962 0.003 0.121 0.103 0.962 0.012 0.124 0.100 0.932
b1 -0.022 0.090 0.092 0.936 -0.017 0.085 0.089 0.934 -0.003 0.011 0.096 0.928
β1 0.014 0.128 0.126 0.942 0.022 0.142 0.131 0.958 0.007 0.118 0.130 0.930
β2 -0.017 0.062 0.066 0.960 -0.007 0.062 0.069 0.940 -0.011 0.071 0.066 0.958
cure-1 0.002 0.027 0.026 0.964 0.005 0.029 0.027 0.958 0.005 0.030 0.027 0.936
cure-2 -0.003 0.025 0.023 0.942 0.001 0.026 0.027 0.932 0.003 0.026 0.025 0.930
in the same magnitudes for the three data sets under both models, and race and
grade both have significant impact on the cure fraction. When race changes from
white to black, the net survival probability becomes smaller. With the level of cancer
cell grade increases, the net survival probability decreases. The effect of background
mortality on the predicted survival probability for younger patients group is smaller
than that for elder patients group. Figure 3.1 - 3.3 show that the predicted survival
probabilities by race are higher by the proposed semiparametric PCPH+BM model
and the white people have higher net survival probability than the black people,
which are consistent with the estimation in Table 3.5.
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Table 3.5: SEER regional female breast cancer: parameters estimation in the semi-
parametric PCPH+BM model and the semiparametric PCPH model, race and grade
are included in both the cure link function and latency survival function. Model I is
to fit the whole data set with 6200 observations, Model II is to fit the subgroup data
of age ≤ 70, and model III is to fit the subgroup data of age > 70.
PCPH+BM PCPH
Par Est StErr CI Est StErr CI
Model I: SEER data γ0 -1.477 0.111 (-1.695,-1.259) -0.477 0.065 (-0.605,-0.349)
γ1 0.505 0.070 (0.369,0.642) 0.113 0.047 (0.022,0.205)
γ2 0.076 0.016 (0.045,0.106) 0.028 0.010 (0.008,0.048)
β1 0.318 0.039 (0.243,0.394) 0.195 0.041 (0.114,0.276)
β2 0.063 0.014 (0.036,0.090) 0.058 0.012 (0.035,0.081)
cure-W 0.623 0.013 (0.598,0.648) 0.470 0.009 (0.452,0.488)
cure-B 0.456 0.020 (0.417,0.495) 0.429 0.017 (0.396,0.462)
Model II: subgroup of age ≤ 70
γ0 -1.740 0.126 (-1.986,-1.493) -1.083 0.091 (-1.262,-0.904)
γ1 0.506 0.077 (0.355,0.657) 0.277 0.061 (0.158,0.397)
γ2 0.081 0.017 (0.046,0.115) 0.039 0.014 (0.012,0.066)
β1 0.193 0.055 (0.085,0.301) 0.201 0.053 (0.097,0.305)
β2 0.047 0.022 (0.004,0.090) 0.052 0.016 (0.022,0.083)
cure-W 0.691 0.013 (0.666,0.716) 0.606 0.012 (0.582,0.630)
cure-B 0.542 0.020 (0.503,0.581) 0.516 0.020 (0.477,0.555)
Model III: subgroup of age > 70
γ0 -1.466 0.239 (-1.933,-0.998) 0.225 0.096 (0.037,0.413)
γ1 0.584 0.158 (0.274,0.894) 0.145 0.082 (-0.015,0.305)
γ2 0.123 0.033 (0.057,0.188) 0.015 0.017 (-0.019,0.048)
β1 0.646 0.050 (0.549,0.743) 0.160 0.075 (0.012,0.307)
β2 0.070 0.015 (0.039,0.100) 0.078 0.020 (0.039,0.118)
cure-W 0.481 0.029 (0.424,0.538) 0.221 0.015 (0.192,0.250)
cure-B 0.312 0.050 (0.214,0.410) 0.174 0.028 (0.119,0.229)
Figure 3.1: Predicted Survival Probability for the SEER regional female breast can-
cer data, the proposed PCPH+BM model estimates cure fraction higher than the
standard PCPH model.
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Figure 3.2: Predicted Survival Probability for the subgroup of age ≤ 70 in the SEER
regional female breast cancer data. The proposed PCPH+BM model estimates cure
fraction higher than the standard PCPH model.
Figure 3.3: Predicted Survival Probability for the subgroup of age > 70 in the SEER
regional female breast cancer data. The proposed PCPH+BM model estimates cure
fraction higher than the standard PCPH model.
3.6 Discussions
The semiparametric PCPH+BM model has desirable performance in estimation of
parameters and cure fraction, and is comparable to fully parametric methods only
when the baseline distribution can be correctly specified. Thus, the proposed semi-
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parametric PCPH+BM model is more flexible in estimation and largely avoid the
problem of misspecification.
There are different properties for the proposed PCPH+BM model, compared to
the MCPH+BM model in Chapter 2. First, in terms of estimation shown in Table
2.6 and 3.5, all the regression parameters are significant with the corresponding confi-
dence interval not containing 0. The point estimators are all in the same magnitude.
The cure rates estimation are pretty close from these two models. In Model I for the
whole data set, the PCPH+BM model estimates the cure rates for the white people
and black people as 62.3% and 45.6%, respectively, compared to 60.5% and 48.7%
under the MCPH+BM model. However, the MCPH+BM model is more efficient in
computation compared to the PCPH+BM model. The former uses a perturbation
variance estimation and the latter adapts resampling variance estimation. Previous
studies on the semiparametric EM algorithm in analyzing survival data with a cure
fraction have shown the estimators are asymptotic normality and there is no po-
tential issue in simulation studies (Peng and Dear, 2000; Peng and Carriere, 2002;
Peng, 2003b; Peng, 2003a; Peng and Zhang, 2008; Cai et al., 2012). The proposed
PCPH+BM model and the MCPH+BM model in Chapter 2 are both to estimate
parameters via semiparametric EM algorithm, which has background survival prob-
abilities and background hazard rates involved in calculation as constant values, and
the asymptotic normality of parameters estimation still hold. The simulation studies
in Section 3.4 also support this claim.
Secondly, the AIC can not be used in semiparametric estimation directly. How-
ever, the model comparison can be conducted by using the difference of AIC values
from the PCPH+BM model and the MCPH+BM model (-2ll) since both models
have the same number of parameters. In the breast cancer data analysis, Model
I, Model II and Model III give −2llModel I = 784.976, −2llModel II = 498.288 and
−2llModel III = 742.842, respectively. Specifically, for the SEER female regional breast
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cancer data, regardless of for young people or elder people, the PCPH+BM model al-
ways estimates the AIC smaller than the MCPH+BM model. Thus, the PCPH+BM
model is selected.
Thirdly, in terms of model structure, the MCPH+BM model is a mixture of two
components, uncured patients and cured patients. The subjects in the MCPH+BM
model have been labeled into two categories. The PCPH+BM model has biological
deviation involving the number of metastasizing-competent tumor cells. From this
perspective, the model selection is also based on the suggestions from domain experts
and research preference.
We also consider to extend the PCPH+BM model to the semiparametric transfor-
mation cure models (Zeng, Yin, and Ibrahim, 2006). In the PCPH+BM model, the
assumption that the promotion time (T̃i, . . . , T̃k) are mutually independent, may not
be realistic since they are unobserved random variables taken on the same subject.
Therefore, a subject-specific frailty ξi is introduced such that conditional on both
Ni = k and ξi, the promotion time (T̃i, . . . , T̃k) are mutually independent with dis-
tribution function F (t). Also, conditional on zi and ξi, Ni has a Poisson distribution
with rate ξiθ(zi), thus ξi represents the heterogeneity of the Poisson rates in the Ni’s.
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Chapter 4
Regression Analysis of Right-Censored Data
Under the Generalized Odds-Rate Model
Abstract
Generalized odds-rate (GOR) models, also referred to as Gρ family in the literature,
are a general class of semiparametric regression models taking the classic propor-
tional hazards model as a limiting case and the proportional odds model as a special
case. Although many approaches have been proposed for analyzing right-censored
data using the GOR models in the literature, most of these studies have assumed ρ
to be known and reported that estimating ρ together with the regression parameters
is problematic. This article investigates the identifiability issues associated with the
GOR models when treating ρ as unknown and proves that all parameters are iden-
tifiable in the conventional regression settings. An novel estimation approach based
on the EM algorithm is proposed for analyzing right-censored data using the GOR
models treating ρ as unknown. The proposed approach provides variance estimation
in closed-form. A comprehensive simulation study has shown that the proposed ap-
proach always has an excellent performance in estimating the regression parameters
and the baseline survival function, but can estimate ρ accurately only when sample
size is very large. The proposed approach is also illustrated by a real data set from
the SEER lung cancer study.
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4.1 Introduction
The proportional hazards (PH) model is the most popular survival models for an-
alyzing censored data in the literature. However, the PH model assumption that
the hazards are proportional for different subgroups implies that the corresponding
survival functions are parallel for these subgroups. This is also violated in real life
data analysis. One possible remedy of this problem is to apply some more flexible
regression models. The generalized odds-rate (GOR) models are a class of more gen-
eral semiparametric regression models. The survival function in the GOR models is
expressed as
S(t|x) = {1 + ρΛ0(t) exp(xᵀβ)}−ρ
−1
, (4.1)
where Λ0(t) is a strictly positive increasing function, β is a p× 1 vector of regression
parameters denoting covariate effects, and ρ is a positive constant. Specifically, as ρ→
0, equation (4.1) leads to a limiting survival function S(t|x) = exp {−Λ0(t)exp(xᵀβ)}
under the Cox PH model. When ρ = 1, equation (4.1) becomes the PO model survival
function S(t|x) = {1 + Λ0(t) exp(xᵀβ)}−1. The GOR models are also well recognized
as a special class of linear transformation models in the form of gρ{S(t|x)} = α(t) +
xᵀβ with gρ(s) = log{(s−ρ − 1)/ρ} for ρ > 0. Note that α(t) = log{Λ0(t)} or in the
form of α(T ) = −xᵀβ + ε, where exp (ε) follows a Pareto distribution with ρ > 0.
The term of (s−ρ − 1)/ρ = Λ0(t) exp(xᵀβ) is the Box-Cox transformation. When
x = 0, the function Λ0(t) can be interpreted as the Box-Cox transformed baseline
survival function, and 1/{1 + Λ0(t)} is the frailty PH model survival function. It is
worth noting that the linear transformation models in the literature do not contain
the additional parameter ρ in the transformation function g. The popular gamma
frailty PH models, which are used for modeling multivariate or clustered failure times,
have the GOR models as the marginal distributions of the failure times.
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Many approaches have been proposed for analyzing right-censored data by us-
ing the GOR models. Harrington and Fleming (1982) proposed the Gρ statistic for
testing the regression parameters in the two-sample setting. Cheng, Wei, and Ying
(1995) and Cheng, Wei, and Ying (1997) proposed a semiparametric approach to
estimate the regression parameters. Scharfstein, Tsiatis, and Gilbert (1998) stud-
ied the NPMLE for the regression parameters when the time-to-event outcome is
subject to right censoring conditional on ρ being fixed and known. Chen, Jin, and
Ying (2002) developed simple martingale-based estimating equations to estimate re-
gression parameters. The theoretical properties and hypothesis tests of the NPMLE
for general transformation models have been studied by Bagdonavicius and Nikulin
(1999); Kosorok, Lee, and Fine (2004); Zeng and Lin (2006) and Song, Kosorok,
and Fine (2009). Some Bayesian approaches have also been developed based on the
GOR models. For example, Hanson and Yang (2007); Hanson and Jara (2013) used
a mixture of finite Polya trees prior for the baseline survival function, and Banerjee
et al. (2007) adopted the piece-wise exponential function for the baseline cumulative
hazard function.
Previous studies on the GOR models are mainly focused on the regression param-
eters estimation by treating ρ as fixed and known. However, such strategy reduces
the flexibility of the GOR models. The simulation study in Zeng, Yin, and Ibrahim
(2006) indicates that the performance of the NPMLEs is poor and the convergence
is problematic with a sample size of 400 considering the estimation of ρ, since the
likelihood function tends to be flat when ρ varies around the true value. In general
it is reported that ρ can not be estimated accurately in the literature. A natural
question is whether the parameters in the GOR models are identifiable.
In this article, we investigate the identifiability problem of the GOR models. Our
investigation has found that the GOR models are non-identifiable in the case when
there are no covariates, but are indeed identifiable in the usual regression settings
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including the commonly seen two-sample or k-sample settings. We further propose
a joint estimating approach of the parameter ρ, the regression parameters, and the
baseline parameters for right-censored data. The proposed approach allows one to
conduct model selection among the GOR models by making inference on ρ in addition
to the conventional interests of identifying significant risk factors and estimating
their effects. The rest of the paper is organized as follows. Section 4.2 discusses the
identifiability issues of the GOR models. Section 4.3 gives the details of the proposed
approach for the regression analysis of right-censored data. Section 4.4 outlines the
simulation studies and Section 4.5 applies the proposed method to the real data.
Section 4.6 provides some conclusions and discussions.
4.2 Identifiability of GOR models
For the GOR models in equation (4.1), previous studies have theoretically proved the
following results for the GOR models without or with covariates (Yao, 2016).
Fact: The GOR models with xᵀβ = 0 are non-identifiable.
For the regression settings, the first case is to include a binary covariate, which
is called two-sample setting. The second case is the general setting when there are
a mixture of continuous and binary covariates. Assuming the p covariates are not
linearly correlated, which means that not any single covariate can not be written as
a linear combination of the others, we have the following results.
Theorem 1: The GOR models defined in (4.1) are identifiable in the case of one
binary covariate.
Theorem 2: The GOR models defined in (4.1) are identifiable in general regres-
sion settings.
To explore the identifiability of ρ by real number examples, we consider the fol-
lowing cases:
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(i) X is generated from bernoulli(0.5) with possible values 0 and 1. Let t is a
sequence of value changing from 0 to 50 with step of 0.1. Let Λ01(t) = t,
β = −1 and ρ1 = 1. Suppose Λ02(t) = aΛ01(t) + bΛ201(t) + cΛ301(t) which is a
transformation of the function Λ01(t), and β2 is unknown and to be estimated.
The estimators ρ2 = 1.43, â = 1.092, b̂ = 0.096, ĉ = −0.001 and β̂2 = −1.152
Figure 4.1: Case i: Solid line is the estimated Λ01(t) and dashed line is the estimated
Λ02(t).
are found to make the maximum of |S1(t|X) − S2(t|X)| = 0.00987 < 0.01.
Figure 4.1 shows the difference between the function Λ01(t) and Λ02(t) in case
i.
(ii) GenerateX from bernoulli(0.5) with possible values 0 and 1. Let t be a sequence
of values changing from 0 to 50 with step of 0.1. Let Λ01(t) = log(1 + t) +
t1.5which is a concave function, β = −1 and ρ1 = 1. Suppose Λ02(t) = aΛ01(t)+
bΛ201(t) + cΛ301(t), and β2 is unknown and to be estimated. A set of parameters
ρ2 = 1.250, â = 1.086, b̂ = 0.033, ĉ = −8e − 05 and β̂2 = −1.105 make
the maximum of |S1(t|X) − S2(t|X)| = 0.00978 < 0.01. Figure 4.2 shows the
difference between function Λ01(t) and Λ02(t) in case ii.
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Figure 4.2: Case ii: Solid line is the estimated Λ01(t) and dashed line is the estimated
Λ02(t).
Thus, two sets of different parameters can be found to lead to two very close survival
functions. The information about ρ is little and there exists weak identifiability
problem in the GOR models.
4.3 The Proposed Method
4.3.1 The GOR model
For the seek of easy computation, we reparameterize τ = 1/ρ and write the survival
function of the GOR model as
S(t|x) = {1 + τ−1Λ0(t) exp(xᵀβ)}−τ .
Under this specification, the corresponding density function and hazard function are
f(t|x) = λ0(t) exp(xᵀβ){1 + τ−1Λ0(t) exp(xᵀβ)}−τ−1
and
h(t|x) = λ0(t) exp(xᵀβ){1 + τ−1Λ0(t) exp(xᵀβ)}−1,
respectively, where λ0(t) is the first derivative of Λ0(t).
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4.3.2 The observed data and likelihood
Let Oi = (yi, δi,xi) denote the observed data for subject i (i = 1, 2, . . . , n), where yi
is the observation time as the minimizer of failure times Ti and censoring time Ci,
δi = I(Ti ≤ Ci) is the censoring indicator taking 1 for exactly observed and 0 for
right-censored failure time, and xi is a vector of covariates for subject i. Under the
independence assumption between the failure time and censoring time, the observed
likelihood function based on observed data O takes the following form
Lobs =
n∏
i=1
[λ0(yi) exp(xᵀiβ){1 + τ−1Λ0(yi) exp(x
ᵀ
iβ)}−1]δi{1 + τ−1Λ0(yi) exp(x
ᵀ
iβ)}−τ
and the logarithm observed likelihood function is
`obs =
n∑
i=1
(
δilog{λ0(yi)}+ δixᵀiβ − δilog{1 + τ−1Λ0(yi) exp(x
ᵀ
iβ)}
− τ log{1 + τ−1Λ0(yi) exp(xᵀiβ)}
)
.
(4.2)
The main research interests in the GOR models are to assess the covariate effects
and to estimate the survival functions for different subgroups for prediction purpose.
These require one to estimate the unknown parameters θ = {ρ,β, λ0(·)}. Estimating
ρ under the GOR models has been regarded as a tough issue in the literature for
right-censored data as mentioned in the introduction section.
4.3.3 Monotone Splines
The cumulative baseline hazard function Λ0(·) is an unspecified increasing function,
and it has infinite-dimensional parameters. Using splines is popular to model non-
parametric functions, and it leads to a finite number of parameters to estimate while
maintaining adequate modeling flexibility by not assuming a specific shape for the
unknown functions. We propose to model Λ0(·) with the monotone splines (Ramsay,
1988)
Λ0(t) =
k∑
l=1
γlbl(t),
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where bl’s are nondecreasing integrated spline basis functions ranging from 0 to 1,
and γ = (γ1, . . . , γL) are nonnegative spline coefficients which can ensure Λ0(·) is
nondecreasing. For spline basis functions, the degree and knots need to be specified
within a time range (Ramsay, 1988). The degree of basis functions controls the overall
smoothness of the basis functions; For instance, the degree d = 1, 2 and 3 correspond
to linear, quadratic and cubic basis functions, respectively, and the specifying of
degree of 2 or 3 would attain adequate smoothness. The placement of knots controls
the overall modeling flexibility such that more knots in a region provides greater
modeling flexibility. The choice of knots in the spline functions can be either equally
spaced or at quartiles (Ramsay, 1988). The number of basis functions k is determined
by k = d + m− 2, which is the sum of the degree and the number of interior knots,
then the spline basis functions will be fully determined with degree and placement of
knots. Ramsay (1988) suggested using a small number of strategically placed interior
knots at median or quartiles. The number of interior knots is further recommended
using approximately 10 to 30 (Wang and Dunson, 2011; Wang and Lin, 2011). The
Akaike’s information criterion (AIC) can be used in selecting the number of knots in
real data application (McMahan, Wang, and Tebbs, 2013).
4.3.4 EM Algorithm
The novel EM algorithm we propose is to estimate θ = (Λ0(·),β, τ) with data aug-
mentation. In the first stage, by introducing a gamma frailty variable φi ∼ Ga(τ, τ)
for subject i = 1, . . . , n where τ is the shape and rate of gamma distribution, the
equation (4.2) involves the survival function
S(t|x) =
∫ ∞
0
e−Λ0(t) exp(x
ᵀβ)φ τ
τφτ−1e−τφ
Γ(τ) dφ. (4.3)
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We further introduce a second-stage latent variable ψi ∼ Ga(1, τ) only for those
exactly observed subjects with δi = 1 such that
{1 + τ−1Λ0(t) exp(xᵀiβ)}−1 =
∫ ∞
0
e−Λ0(t) exp(x
ᵀ
i β)ψiτe−τψidψi.
The third-stage latent variable is a Zi ∼ multinomial[1, ( 1k ,
1
k
, . . . , 1
k
)] only for
those exactly observed subjects with δi = 1. Hence, the complete likelihood function
with the three sets of latent variables is written as
Lc =
n∏
i=1
([ k∏
l=1
{γlMl(yi)}Zil exp(xᵀiβ) exp {−Λ0(yi) exp(x
ᵀ
iβ)ψi − τψi}τ
]δi
× exp {−Λ0(yi) exp(xᵀiβ)φi}
τ τφτ−1i e
−τφi
Γ(τ)
)
.
(4.4)
In the EM algorithm, the E-step is to take the conditional expectation of the
logarithm complete likelihood function (4.4) with respect to the latent variables φi’s,
ψi’s and Zil’s, given the observed data O and the current parameters θ(d) at dth itera-
tion, which is denoted as Q(θ,θ(d)) = E[log{Lc(θ)}|O;θ(d)]. The expected logarithm
complete likelihood functions can be written as the summation of two parts,
Q1(β,γ,θ(d)) =
n∑
i=1
δi
[ k∑
l=1
E(Zil|O;θ(d))log{γlMl(yi)}
]
+ δixᵀiβ
− δi
k∑
l=1
γlbl(yi) exp(xᵀiβ)E(ψi|O;θ(d))
−
k∑
l=1
γlbl(yi) exp(xᵀiβ)E(φi|O;θ(d)),
(4.5)
and
Q2(τ,θ(d)) =
n∑
i=1
−δiτE(ψi|O;θ(d)) + δilog(τ)− τE(φi|O;θ(d)) + τ log(τ)
+ (τ − 1)E(logφi|O;θ(d))− log{Γ(τ)}.
(4.6)
Note from the complete likelihood function in (4.4), the latent variables condi-
tional on the observed data O and the current updated parameters θ(d) are
ψi|(O;θ(d)) ∼ Ga
(
1,Λ0(yi) exp(xᵀiβ) + τ
)
for the exactly observed subjects with
δi = 1, and φi|(O;θ(d)) ∼ Ga
(
τ,Λ0(yi) exp(xᵀiβ) + τ
)
where Λ0(yi) =
∑k
l=1 γlbl(yi)
76
and λ0(yi) =
∑k
l=1 γlMl(yi). The conditional expectations involved in equation (4.5)
and (4.6) all have explicit forms as follows,
E(ψi|O;θ(d)) =
δi
Λ(d)0 (yi) exp(xᵀiβ(d)) + τ (d)
,
E(φi|O;θ(d)) =
τ
Λ(d)0 (yi) exp(xᵀiβ(d)) + τ (d)
,
E(Zij|O;θ(d)) =
γ
(d)
j Mj(yi)∑k
l=1 γ
(d)
l Ml(yi)
δi,
and
E{log(φ)|O;θ(d)} = Γ
′(τ)
Γ(τ) − log{Λ
(d)
0 (yi) exp(xᵀiβ(d)) + τ (d)}.
The M-step is to maximize the equations (4.5) and (4.6) with respect to the
unknown parameters θ by taking partial derivatives and setting them to zero such
that,
∂Q(θ,θ(d))
∂γj
=
n∑
i=1
δiE(Zij|O;θ(d))
γj
− δi exp(xᵀiβ)E(ψi|O;θ(d))bj(yi) (4.7)
− exp(xᵀiβ)E(φi|O;θ(d))bj(yi) = 0
∂Q(θ,θ(d))
∂β
=
n∑
i=1
δiXi − δi{
k∑
j=1
γjbj(yi)}E(ψi|O;θ(d)) exp(xᵀiβ)xi (4.8)
− {
k∑
j=1
γjbj(yi)}E(φi|O;θ(d)) exp(xᵀiβ)xi = 0
∂Q(θ,θ(d))
∂τ
=
n∑
i=1
−δiE(ψi|O;θ(d)) + δiτ−1 − E(φi|O;θ(d)) + log(τ) + 1
+ E(logφi|O;θ(d))−
Γ′(τ)
Γ(τ) = 0.
Note that the equation (4.7) leads to a closed form for γj as a function of β,
γ∗j (β) =
∑n
i=1 δiE(Zij|O;θ(d))∑n
i=1 δi exp(x
ᵀ
iβ)E(ψi|O;θ(d))bj(yi) + exp(x
ᵀ
iβ)E(φi|O;θ(d))bj(yi)
, (4.9)
j = 1, . . . , k.
Thus, one can replace γj with γ∗j (β) for each j in the equation (4.8) and solve
for β(d+1). Then γ(d+1)j is obtained as γ∗j (β(d+1)), for j = 1, . . . , k. The proposed EM
algorithm to estimate parameters θ = (γj=1,2,...,k,β, τ) can be summarized as follows,
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Step 0: Set initial values β0 as 0.1, τ 0 as 1, and the spline parameters r(0)j=1,2,...,k as
0.1;
Step 1: Obtain β(d+1) by solving the p equations in (4.8), where
γ
∗(d)
j (β) =
∑n
i=1 δiE(Zij|O;θ(d))∑n
i=1 δi exp(x
ᵀ
iβ)E(ψi|O;θ(d))bj(yi) + exp(x
ᵀ
iβ)E(φi|O;θ(d))bj(yi)
,
j = 1, . . . , k.
Step 2: Update γ(d+1)j = γ
∗(d)
j (β(d+1)) for j = 1, . . . , k and increase d by 1.
Step 3: Obtain τ (d+1) by solving the equation ∑ni=1−δiE(ψi|O;θ(d)) + δiτ−1
− E(φi|O;θ(d)) + log(τ) + 1 + E(logφi|O;θ(d))Γ′(τ)/Γ(τ) = 0.
Repeat Step 1 - Step 3 until convergence. The convergence of the EM algorithm
is claimed when the maximum change of all elements of β, γj’s and τ between suc-
cessive iterations is less than a prespecified small value ε, say 10−7. The proposed
EM algorithm has two likelihood functions involving separate parameters which is
appealing in computation. Moreover, the updated γ(d+1)j can be guaranteed to be
nonnegative from equation (4.9), so there is no constrain needed when estimate γj.
The estimator for ρ is transformed back as ρ̂ = τ̂−1.
For variance estimation, let θ̂ denote the converged values of θ(d) = (γ(d)
′
,β(d)
′
,
τ (d)
′
)′ and θ̂ is a maximum likelihood estimator of θ. Variance can be estimated by
Louis’s method (Louis, 1982) which provides closed-form expressions for all parame-
ters. Specifically, var(θ̂) is the inverse of the observed information matrix I(θ̂) and
I(θ) is obtained using the missing information principle as follows,
I(θ) = −∂
2Q(θ, θ̂)
∂θ∂θ′
− var
(
∂logLc(θ)
∂θ
|O, θ̂
)
. (4.10)
All the quantities involved to calculate these two terms in equation (4.10) have
closed-form expressions, and the details are shown in the Appendix A. Those closed-
form expressions make the variance estimation easy to compute, which is another
appealing point in the proposed approach.
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The proposed approach allows one to make inference on ρ. This is appealing since
it provides plausible values of ρ based on the 95% confidence interval for a specific
data set using the GOR model. Also, we can validate the PO model assumption by
conducting a formal hypothesis test about ρ = 1.
As the PH model is the limiting case of the GOR models when ρ→ 0, a simplified
version of the proposed EM algorithm can be used for the PH model. We provide
some details of the EM algorithm and the variance estimation under the PH model
in Appendix B.
4.4 Simulation
A comprehensive simulation study was conducted to assess the performance of the
proposed approach. The failure time was generated from
S(t|xi) = {1 + ρΛ0(t) exp(xᵀβ)}−ρ
−1
,
where xi = (xi1, xi2) are two representative continuous and discrete covariates with
xi1 ∼ N(0, 1) and xi2 ∼ Bernoulli(0.5). The true baseline cumulative function was
taken to be a concave function Λ0(t) = log(1 + t) + t1.5 and a convex function
Λ0(t) = 0.5t5/6 in two simulation scenarios. The regression parameters were set
as β = c(−1,−1), and ρ took on 0.5, 1, 2 and as well as two relatively extreme values
of 0.25 and 4. The right-censoring time Ci was generated from an exponential distri-
bution with parameter c to control the censoring rate. For example, in the concave
function Λ0(t) = log(1 + t) + t1.5 and ρ = 1, taking c to be 0.1, 0.4, and 3 corresponds
to a right-censoring rate about 20%, 40%, and 75%, respectively. We generated 500
independent data sets, each with a sample size of n = 200, 500, 800, 1000 and 1500
for each parameter configuration.
For each data set, we ran the proposed method described in Section 4.3 under the
GOR model. We used interior knots of 10 and degree of 3 for adequate smoothness for
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the monotone spline specification. The initial values for β1 and β2 were both 0.1, the
initial value for τ was 1, and the initial values for γls were set as 0.1. The convergence
was claimed when the maximum changes of all parameters for two successive iterations
was smaller than 10−7.
The summary statistics include the difference between the average of 500 point
estimates and true values (bias), the average of 500 estimated standard errors (StErr),
the empirical standard deviations of 500 point estimates (StDev) and the 95% cov-
erage probability (CP). Tables 4.1 and 4.2 illustrate that the proposed method gives
good estimation in large sample size of 1000 or 1500 in both concave and convex
baseline cumulative baseline functions. As seen, biases are small for all parameters;
StErrs are close to StDevs indicating the variance estimation based on Louis’s method
are accurate; all the 95% CPs are close to the nominal value 0.95 which indicates the
asymptotic normality of the parameter estimation is valid. It is also observed that
the StErrs tend to become smaller as ρ changes from 2 to 0.5, since larger ρ results
in less information about the failure time in data. High censored rate data tends to
have larger variances estimation than low censored rate data. Figures 4.3 and 4.10
show that the estimated baseline survival probability is very close to the true base-
line survival function for low censored rate and medium censored rate data, and the
corresponding confidence interval becomes narrower when sample size increases. The
weak identifiability issue in the GOR models makes the estimation of the regression
parameters β and the parameter ρ all less precise since all the parameters react with
each other in the EM algorithm.
In Tables 4.3 and 4.4, we explored the performance of the proposed EM algorithm
in extreme cases of ρ = 4 when frailty variance is large and ρ = 0.25 when frailty
variance is small in the equation (4.3). In the setup of ρ = 4 for low censored rate
data, larger sample size such as 2500 is needed to provide good estimation, while on
the contrary, the performance of the proposed EM algorithm is good enough in the
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Table 4.1: Summary Statistics of the proposed method with concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2, ρ = 1 and ρ = 0.5 with 3 levels censoring rate
(around 20% in I: Low Censored, 40% in II: Medium Censored and 75% in III: High
Censored).
ρ = 2 ρ = 1 ρ = 0.5
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
I: Low Censored
n=200 β1 -0.074 0.247 0.335 0.834 -0.028 0.221 0.222 0.918 -0.036 0.230 0.215 0.936
β2 -0.081 0.379 0.472 0.902 -0.042 0.321 0.333 0.934 -0.019 0.303 0.290 0.926
ρ 0.246 0.729 1.347 0.666 0.055 0.497 0.571 0.836 0.008 0.354 0.356 0.876
n=500 β1 -0.031 0.164 0.183 0.912 -0.008 0.134 0.138 0.938 0.003 0.114 0.116 0.948
β2 -0.021 0.243 0.261 0.930 -0.009 0.194 0.194 0.948 -0.004 0.163 0.176 0.938
ρ 0.101 0.572 0.701 0.880 -0.008 0.309 0.342 0.890 -0.018 0.197 0.202 0.930
n=800 β1 -0.013 0.131 0.134 0.932 -0.015 0.106 0.105 0.950 -0.004 0.090 0.092 0.944
β2 -0.016 0.193 0.187 0.958 -0.011 0.154 0.160 0.928 -0.000 0.128 0.135 0.932
ρ 0.048 0.464 0.493 0.914 0.027 0.247 0.251 0.936 -0.004 0.154 0.162 0.940
n=1000 β1 -0.003 0.116 0.121 0.932 -0.006 0.094 0.097 0.932 -0.000 0.080 0.082 0.932
β2 -0.008 0.172 0.175 0.942 -0.005 0.137 0.144 0.934 0.001 0.114 0.118 0.948
ρ 0.027 0.414 0.442 0.942 0.013 0.221 0.230 0.938 -0.007 0.137 0.138 0.950
n=1500 β1 -0.012 0.094 0.096 0.944 0.000 0.076 0.073 0.962 0.005 0.065 0.061 0.950
β2 -0.013 0.139 0.143 0.956 -0.000 0.110 0.104 0.956 0.004 0.093 0.090 0.956
ρ 0.046 0.332 0.354 0.938 0.001 0.176 0.168 0.954 -0.006 0.111 0.101 0.976
II: Medium Censored
n=200 β1 -0.076 0.268 0.353 0.868 -0.053 0.259 0.257 0.918 -0.027 0.313 0.227 0.948
β2 -0.079 0.399 0.455 0.918 -0.055 0.361 0.360 0.920 -0.033 0.399 0.312 0.924
ρ 0.242 0.923 1.479 0.786 0.096 0.630 0.767 0.854 0.013 0.454 0.498 0.874
n=500 β1 -0.016 0.173 0.178 0.944 -0.013 0.145 0.151 0.940 -0.010 0.127 0.122 0.946
β2 0.001 0.249 0.260 0.928 -0.016 0.209 0.216 0.938 0.002 0.181 0.181 0.954
ρ 0.008 0.657 0.687 0.918 0.013 0.382 0.413 0.924 0.022 0.263 0.269 0.926
n=800 β1 -0.021 0.139 0.144 0.930 -0.004 0.111 0.107 0.968 -0.008 0.098 0.098 0.954
β2 -0.017 0.202 0.210 0.952 -0.005 0.162 0.148 0.962 -0.007 0.142 0.142 0.948
ρ 0.081 0.542 0.565 0.936 -0.016 0.292 0.279 0.946 -0.010 0.200 0.199 0.946
n=1000 β1 -0.003 0.120 0.123 0.946 -0.005 0.102 0.103 0.938 -0.013 0.088 0.090 0.952
β2 -0.017 0.177 0.179 0.962 -0.004 0.147 0.149 0.940 -0.009 0.127 0.124 0.964
ρ 0.036 0.465 0.483 0.936 -0.001 0.269 0.270 0.934 0.012 0.179 0.190 0.936
n=1500 β1 -0.002 0.097 0.097 0.954 0.006 0.080 0.080 0.944 -0.005 0.071 0.069 0.964
β2 -0.012 0.143 0.138 0.962 0.004 0.117 0.121 0.952 -0.007 0.103 0.102 0.958
ρ 0.012 0.372 0.372 0.948 -0.007 0.211 0.221 0.938 0.001 0.144 0.142 0.950
III: High Censored
n=200 β1 -0.288 0.376 1.293 0.866 -0.172 0.334 0.787 0.912 -0.104 0.381 0.485 0.934
β2 -0.318 0.553 2.050 0.860 -0.091 0.486 0.761 0.906 -0.078 0.570 0.500 0.906
ρ 1.954 1.859 10.658 0.676 0.672 1.210 4.432 0.768 0.476 1.130 2.646 0.620
n=500 β1 -0.035 0.228 0.246 0.928 -0.033 0.204 0.202 0.936 -0.034 0.190 0.161 0.956
β2 -0.021 0.333 0.325 0.932 -0.035 0.293 0.277 0.942 -0.046 0.268 0.260 0.932
ρ 0.198 1.341 1.550 0.898 0.095 0.842 0.818 0.930 0.100 0.641 0.598 0.942
n=800 β1 -0.014 0.170 0.170 0.948 -0.023 0.148 0.153 0.952 -0.019 0.134 0.128 0.954
β2 -0.024 0.250 0.260 0.936 -0.026 0.217 0.231 0.928 -0.012 0.195 0.194 0.942
ρ 0.057 0.961 1.024 0.922 0.065 0.606 0.596 0.944 0.065 0.467 0.415 0.996
n=1000 β1 -0.020 0.153 0.152 0.948 -0.008 0.128 0.126 0.954 -0.021 0.120 0.117 0.946
β2 -0.018 0.224 0.229 0.940 -0.015 0.191 0.192 0.938 -0.017 0.173 0.170 0.948
ρ 0.083 0.870 0.941 0.938 0.007 0.533 0.518 0.926 0.035 0.402 0.372 0.986
n=1500 β1 -0.008 0.120 0.123 0.952 -0.011 0.104 0.093 0.972 -0.009 0.095 0.095 0.946
β2 -0.023 0.177 0.173 0.950 -0.007 0.155 0.154 0.958 -0.005 0.140 0.138 0.948
ρ 0.031 0.667 0.714 0.952 0.016 0.421 0.387 0.950 0.021 0.316 0.294 0.976
sample size of 500 for ρ = 0.25. This makes sense because the larger frailty variance
is, the less information we can get from the data.
The proposed EM algorithm was compared to the direct MLE algorithm in Table
4.5 for different censored rates data, and the former algorithm always performs better
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Table 4.2: Summary Statistics of the proposed method with convex function Λ0(t) =
0.5t5/6, β = c(−1,−1), ρ = 2, ρ = 1 and ρ = 0.5 with 3 levels censoring rate (around
20% in I: Low Censored, 40% in II: Medium Censored and 75% in III: High Censored).
ρ = 2 ρ = 1 ρ = 0.5
Par Bias StErr StDev CP Bias StErr StDev CP Bias StErr StDev CP
I: Low Censored
n=200 β1 -0.124 0.263 0.426 0.812 -0.052 0.217 0.239 0.898 -0.027 0.213 0.200 0.934
β2 -0.124 0.263 0.426 0.812 -0.042 0.320 0.321 0.932 -0.048 0.295 0.296 0.926
ρ 0.516 0.817 1.711 0.698 0.101 0.483 0.618 0.800 0.007 0.339 0.398 0.824
n=500 β1 -0.028 0.169 0.188 0.862 -0.019 0.138 0.144 0.920 -0.014 0.123 0.115 0.950
β2 -0.034 0.249 0.259 0.918 -0.021 0.200 0.208 0.926 -0.000 0.172 0.166 0.956
ρ 0.149 0.606 0.665 0.824 0.045 0.322 0.348 0.878 0.009 0.224 0.206 0.928
n=800 β1 -0.026 0.139 0.135 0.938 -0.014 0.107 0.109 0.936 -0.006 0.092 0.092 0.940
β2 -0.020 0.197 0.192 0.922 -0.014 0.154 0.157 0.952 -0.006 0.131 0.130 0.960
ρ 0.100 0.510 0.489 0.938 0.019 0.247 0.260 0.898 -0.007 0.167 0.167 0.936
n=1000 β1 -0.014 0.117 0.112 0.946 -0.012 0.096 0.095 0.944 -0.004 0.083 0.085 0.956
β2 -0.001 0.170 0.172 0.932 -0.016 0.138 0.138 0.940 -0.002 0.117 0.114 0.956
ρ 0.052 0.425 0.400 0.926 0.021 0.223 0.216 0.930 0.001 0.150 0.155 0.936
n=1500 β1 -0.013 0.098 0.092 0.950 -0.005 0.077 0.077 0.944 -0.001 0.066 0.064 0.968
β2 -0.001 0.141 0.140 0.936 -0.007 0.111 0.110 0.948 0.003 0.094 0.091 0.954
ρ 0.034 0.356 0.309 0.946 0.008 0.180 0.175 0.942 -0.008 0.119 0.112 0.950
II: Medium Censored
n=200 β1 -0.095 0.270 0.509 0.868 -0.062 0.243 0.318 0.898 -0.035 0.337 0.210 0.934
β2 -0.067 0.400 0.517 0.896 -0.045 0.340 0.374 0.912 -0.050 0.420 0.298 0.942
ρ 0.396 0.984 2.256 0.764 0.115 0.595 0.930 0.782 0.060 0.473 0.487 0.832
n=500 β1 -0.023 0.170 0.187 0.904 -0.017 0.152 0.138 0.938 -0.006 0.130 0.128 0.946
β2 -0.034 0.251 0.258 0.918 -0.015 0.213 0.204 0.930 -0.007 0.183 0.177 0.952
ρ 0.065 0.662 0.691 0.904 0.040 0.407 0.399 0.890 0.009 0.277 0.258 0.934
n=800 β1 -0.027 0.144 0.135 0.950 -0.005 0.113 0.109 0.954 -0.008 0.102 0.101 0.954
β2 -0.010 0.203 0.194 0.950 0.004 0.162 0.160 0.938 -0.011 0.144 0.142 0.954
ρ 0.073 0.580 0.499 0.948 0.013 0.305 0.299 0.940 0.013 0.218 0.209 0.950
n=1000 β1 -0.021 0.124 0.123 0.950 -0.012 0.100 0.098 0.954 -0.009 0.089 0.089 0.950
β2 -0.019 0.179 0.165 0.966 -0.019 0.145 0.140 0.956 0.001 0.126 0.123 0.956
ρ 0.079 0.491 0.473 0.948 0.029 0.270 0.277 0.950 0.015 0.189 0.179 0.964
n=1500 β1 -0.022 0.100 0.102 0.930 -0.001 0.080 0.084 0.940 -0.006 0.071 0.070 0.947
β2 -0.020 0.145 0.149 0.942 -0.009 0.117 0.109 0.958 -0.000 0.102 0.103 0.930
ρ 0.077 0.393 0.388 0.942 0.006 0.216 0.230 0.930 -0.000 0.150 0.142 0.957
III: High Censored
n=200 β1 -0.350 0.396 1.480 0.806 -0.203 0.352 0.921 0.890 -0.151 0.422 0.831 0.926
β2 -0.332 0.570 1.804 0.864 -0.256 0.522 1.127 0.904 -0.128 0.583 0.576 0.916
ρ 2.587 2.277 11.914 0.698 1.248 1.497 7.592 0.692 0.696 1.240 4.780 0.632
n=500 β1 -0.038 0.226 0.245 0.930 -0.035 0.206 0.207 0.930 -0.042 0.196 0.167 0.972
β2 -0.047 0.329 0.343 0.944 -0.062 0.298 0.286 0.952 -0.024 0.271 0.239 0.940
ρ 0.217 1.404 1.653 0.902 0.153 0.931 1.001 0.896 0.098 0.750 0.590 0.928
n=800 β1 -0.016 0.175 0.172 0.954 -0.008 0.153 0.142 0.950 -0.024 0.142 0.138 0.948
β2 -0.018 0.256 0.250 0.962 -0.025 0.225 0.214 0.956 -0.025 0.204 0.202 0.942
ρ 0.038 1.087 1.103 0.942 0.019 0.720 0.665 0.930 0.087 0.567 0.482 0.982
n=1000 β1 -0.019 0.155 0.159 0.950 -0.018 0.134 0.128 0.962 -0.016 0.123 0.113 0.968
β2 -0.040 0.229 0.245 0.928 -0.010 0.197 0.190 0.956 -0.013 0.177 0.181 0.924
ρ 0.109 0.971 1.016 0.954 0.085 0.619 0.624 0.954 0.061 0.479 0.417 0.992
n=1500 β1 0.005 0.121 0.117 0.950 -0.010 0.108 0.107 0.944 -0.010 0.097 0.096 0.954
β2 0.006 0.179 0.190 0.942 -0.003 0.158 0.149 0.956 -0.013 0.145 0.147 0.948
ρ -0.048 0.737 0.776 0.960 0.002 0.487 0.462 0.932 0.031 0.370 0.326 0.986
than the latter for different censored rates and sample sizes. This superiority also
exists in other settings (not shown).
We provide illustration on model testing in terms of ρ. For example, for testing
the PO model (ρ = 1), Table 4.6 presents the power analysis for rejecting ρ = 1. The
sample size n = 1500 was used. Under the PO model, the power is very close to the
nominal value 0.05 when the true value ρ = 1, and the power for other values of ρ is
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Table 4.3: Summary Statistics of the proposed method with concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1) and in extreme cases of ρ = 4 and ρ = 0.25 with 3
levels censoring rate (around 20% in I: Low Censored, 40% in II: Medium Censored
and 75% in III: High Censored). Larger ρ provides larger frailty variance, and the
setup under ρ = 4 needs much larger sample size to provide stable performance.
ρ = 4 ρ = 0.25
Par Bias StErr StDev CP Bias StErr StDev CP
I: Low Censored
n=200 β1 -0.102 0.266 0.454 0.770 -0.026 0.373 0.167 0.960
β2 -0.094 0.448 0.621 0.868 -0.019 0.430 0.237 0.956
ρ 0.443 0.824 2.555 0.462 -0.002 0.269 0.242 0.922
n=500 β1 0.161 0.142 0.200 0.616 -0.002 0.110 0.110 0.928
β2 0.175 0.235 0.265 0.802 -0.012 0.150 0.148 0.934
ρ -1.259 0.488 0.994 0.320 -0.009 0.153 0.148 0.976
n=800 β1 0.170 0.115 0.164 0.506 -0.003 0.082 0.080 0.950
β2 0.162 0.191 0.221 0.734 -0.002 0.114 0.113 0.942
ρ -1.298 0.459 0.798 0.300 -0.004 0.117 0.116 0.952
n=1000 β1 -0.011 0.141 0.161 0.888 -0.001 0.073 0.074 0.938
β2 -0.012 0.216 0.244 0.904 -0.001 0.102 0.100 0.946
ρ 0.122 0.754 1.074 0.738 -0.007 0.105 0.107 0.936
n=1500 β1 -0.012 0.121 0.129 0.897 -0.008 0.059 0.060 0.948
β2 -0.018 0.182 0.193 0.940 -0.010 0.084 0.084 0.960
ρ 0.130 0.696 0.897 0.820 0.004 0.085 0.088 0.928
n=2500 β1 0.001 0.095 0.093 0.951 0.001 0.046 0.045 0.946
β2 -0.004 0.142 0.144 0.934 -0.002 0.065 0.065 0.956
ρ 0.038 0.582 0.594 0.923 -0.001 0.065 0.065 0.960
II: Medium Censored
n=200 β1 -0.167 0.304 0.564 0.768 -0.035 0.453 0.191 0.954
β2 -0.129 0.483 0.715 0.818 -0.021 0.512 0.246 0.958
ρ 1.092 1.311 3.759 0.510 0.014 0.373 0.310 0.912
n=500 β1 -0.048 0.214 0.244 0.908 -0.015 0.137 0.112 0.962
β2 -0.069 0.324 0.345 0.920 -0.011 0.180 0.155 0.948
ρ 0.319 1.296 1.655 0.852 -0.001 0.203 0.181 0.990
n=800 β1 -0.010 0.173 0.182 0.924 -0.012 0.092 0.090 0.942
β2 -0.025 0.258 0.273 0.942 -0.017 0.129 0.130 0.946
ρ 0.155 1.097 1.328 0.898 0.017 0.156 0.148 0.978
n=1000 β1 -0.019 0.156 0.162 0.936 0.003 0.079 0.079 0.944
β2 -0.014 0.231 0.233 0.944 0.003 0.112 0.107 0.958
ρ 0.162 1.005 1.070 0.934 -0.013 0.133 0.134 0.946
n=1500 β1 0.002 0.124 0.137 0.918 -0.001 0.064 0.066 0.928
β2 -0.002 0.185 0.189 0.944 0.001 0.092 0.090 0.938
ρ 0.028 0.796 0.873 0.922 -0.003 0.108 0.105 0.950
III: High Censored
n=200 β1 -0.526 0.403 1.731 0.766 -0.110 0.379 0.512 0.956
β2 -0.454 0.605 1.914 0.804 -0.087 0.506 0.433 0.944
ρ 4.845 3.037 16.944 0.664 0.327 0.742 2.143 0.614
n=500 β1 -0.047 0.256 0.277 0.888 -0.046 0.220 0.146 0.972
β2 -0.050 0.377 0.389 0.908 -0.029 0.279 0.228 0.932
ρ 0.432 2.174 2.503 0.874 0.080 0.513 0.390 0.920
n=800 β1 -0.037 0.202 0.212 0.938 -0.021 0.143 0.116 0.960
β2 -0.023 0.295 0.313 0.934 -0.029 0.194 0.178 0.940
ρ 0.256 1.711 2.001 0.902 0.064 0.394 0.301 0.986
n=1000 β1 -0.033 0.182 0.188 0.940 -0.006 0.111 0.098 0.956
β2 -0.026 0.263 0.271 0.934 -0.004 0.156 0.156 0.916
ρ 0.252 1.533 1.608 0.924 0.013 0.326 0.243 0.988
n=1500 β1 -0.006 0.143 0.137 0.942 -0.006 0.086 0.087 0.934
β2 -0.009 0.211 0.207 0.946 -0.014 0.126 0.128 0.930
ρ 0.048 1.177 1.121 0.940 0.039 0.256 0.227 0.988
higher when ρ is farther away from ρ = 1. High censored rate data tends to provide
lower power than low censored rate data since the likelihood function is less sharply
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Table 4.4: Summary Statistics of the proposed method with convex function Λ0(t) =
0.5t5/6, β = c(−1,−1) and in extreme cases of ρ = 4 and ρ = 0.25 with 3 levels
censoring rate (around 20% in I: Low Censored, 40% in II: Medium Censored and
75% in III: High Censored). Similar to the concave function Λ0(t), a larger ρ provides
larger frailty variance, and the setup under ρ = 4 needs much larger sample size to
provide stable performance.
ρ = 4 ρ = 0.25
Par Bias StErr StDev CP Bias StErr StDev CP
I: Low Censored
n=200 β1 -0.200 0.278 0.543 0.798 -0.031 0.246 0.161 0.958
β2 -0.168 0.477 0.707 0.854 -0.030 0.304 0.241 0.936
ρ 1.572 0.775 3.523 0.394 0.010 0.312 0.240 0.884
n=500 β1 -0.071 0.178 0.244 0.826 -0.017 0.110 0.099 0.950
β2 -0.050 0.296 0.351 0.894 -0.013 0.152 0.139 0.960
ρ 0.677 0.739 1.794 0.518 0.009 0.164 0.150 0.962
n=800 β1 -0.041 0.148 0.178 0.838 -0.005 0.083 0.083 0.960
β2 -0.047 0.243 0.280 0.902 -0.003 0.116 0.116 0.948
ρ 0.327 0.814 1.114 0.682 -0.002 0.124 0.114 0.960
n=1000 β1 -0.022 0.133 0.153 0.872 -0.009 0.074 0.075 0.942
β2 -0.021 0.212 0.249 0.892 -0.010 0.104 0.108 0.938
ρ 0.303 0.759 1.030 0.774 0.006 0.110 0.109 0.952
n=1500 β1 -0.006 0.116 0.117 0.888 0.001 0.059 0.057 0.960
β2 -0.021 0.179 0.192 0.902 -0.006 0.084 0.080 0.946
ρ 0.118 0.736 0.705 0.890 -0.003 0.087 0.087 0.956
n=2500 β1 -0.003 0.096 0.094 0.916 -0.001 0.046 0.046 0.948
β2 -0.004 0.144 0.142 0.932 -0.002 0.065 0.069 0.926
ρ 0.106 0.627 0.563 0.932 0.001 0.067 0.065 0.962
II: Medium Censored
n=200 β1 -0.275 0.321 0.833 0.750 -0.044 0.255 0.198 0.946
β2 -0.228 0.516 0.928 0.846 -0.056 0.326 0.288 0.952
ρ 2.127 1.454 5.199 0.498 0.060 0.434 0.331 0.866
n=500 β1 -0.059 0.208 0.268 0.862 -0.024 0.122 0.113 0.936
β2 -0.043 0.319 0.364 0.892 -0.019 0.165 0.167 0.918
ρ 0.544 1.296 2.003 0.790 0.015 0.231 0.194 0.972
n=800 β1 -0.024 0.177 0.198 0.888 -0.008 0.090 0.088 0.938
β2 -0.011 0.257 0.270 0.898 -0.011 0.127 0.123 0.948
ρ 0.257 1.188 1.413 0.892 0.005 0.167 0.158 0.992
n=1000 β1 -0.016 0.151 0.174 0.880 -0.006 0.081 0.079 0.960
β2 -0.014 0.226 0.238 0.936 -0.004 0.114 0.113 0.950
ρ 0.176 0.997 1.153 0.908 0.008 0.148 0.137 0.984
n=1500 β1 -0.005 0.124 0.128 0.916 -0.005 0.066 0.063 0.962
β2 -0.001 0.183 0.186 0.930 -0.006 0.093 0.095 0.940
ρ 0.148 0.831 0.822 0.948 0.004 0.118 0.117 0.984
III: High Censored
n=200 β1 -0.776 0.457 2.468 0.734 -0.169 0.317 0.529 0.942
β2 -0.684 0.661 2.736 0.778 -0.193 0.446 0.745 0.920
ρ 7.558 3.423 24.191 0.606 0.554 0.961 3.068 0.590
n=500 β1 -0.044 0.268 0.300 0.904 -0.052 0.176 0.149 0.968
β2 -0.040 0.390 0.431 0.928 -0.050 0.250 0.239 0.940
ρ 0.762 2.501 3.208 0.838 0.179 0.641 0.485 0.936
n=800 β1 -0.023 0.207 0.225 0.922 -0.030 0.136 0.115 0.978
β2 -0.031 0.299 0.326 0.924 -0.031 0.193 0.181 0.940
ρ 0.402 1.895 2.369 0.892 0.107 0.487 0.323 0.986
n=1000 β1 -0.026 0.187 0.193 0.930 -0.028 0.114 0.105 0.964
β2 -0.031 0.269 0.281 0.928 -0.030 0.165 0.163 0.940
ρ 0.451 1.716 1.901 0.924 0.095 0.406 0.325 0.984
n=1500 β1 -0.017 0.154 0.155 0.936 -0.019 0.090 0.082 0.972
β2 -0.006 0.224 0.211 0.954 -0.017 0.134 0.126 0.956
ρ 0.316 1.398 1.399 0.926 0.051 0.307 0.243 0.990
peaked. For both the concave and convex cumulative baseline hazard functions, the
power analysis are similar.
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Table 4.5: Summary Statistics for concave function Λ0(t) = log(1 + t) + t1.5, β =
c(−1,−1), ρ = 2 with 3 levels censoring rate (around 20% in I: Low Censored,
40% in II: Medium Censored and 75% in III: High Censored), the proposed EM
algorithm performs much better than the direct MLE algorithm. In other settings,
EM algorithm also performs better and the results are not shown.
EM Algorithm Direct MLE
Par Bias StErr StDev CP Bias StErr StDev CP
I: Low Censored
n=200 β1 -0.074 0.247 0.335 0.834 0.229 0.190 0.329 0.562
β2 -0.081 0.379 0.472 0.902 0.267 0.293 0.402 0.632
ρ 0.246 0.729 1.347 0.666 -0.910 0.501 1.061 0.436
n=500 β1 -0.031 0.164 0.183 0.912 0.303 0.114 0.211 0.334
β2 -0.021 0.243 0.261 0.930 0.359 0.169 0.272 0.432
ρ 0.101 0.572 0.701 0.880 -1.159 0.278 0.660 0.210
n=800 β1 -0.013 0.131 0.134 0.932 0.308 0.092 0.183 0.292
β2 -0.016 0.193 0.187 0.958 0.362 0.134 0.223 0.354
ρ 0.048 0.464 0.493 0.914 -1.170 0.220 0.563 0.142
n=1000 β1 -0.003 0.116 0.121 0.932 0.302 0.080 0.189 0.260
β2 -0.008 0.172 0.175 0.942 0.347 0.119 0.218 0.346
ρ 0.027 0.414 0.442 0.942 -1.143 0.195 0.564 0.130
n=1500 β1 -0.012 0.094 0.096 0.944 0.308 0.065 0.195 0.192
β2 -0.013 0.139 0.143 0.956 0.359 0.097 0.211 0.246
ρ 0.046 0.332 0.354 0.938 -1.167 0.153 0.548 0.064
II: Medium Censored
n=200 β1 -0.076 0.268 0.353 0.868 0.119 0.221 0.320 0.714
β2 -0.079 0.399 0.455 0.918 0.140 0.331 0.416 0.800
ρ 0.242 0.923 1.479 0.786 -0.587 0.696 1.195 0.638
n=500 β1 -0.016 0.173 0.178 0.944 0.209 0.135 0.188 0.578
β2 0.001 0.249 0.260 0.928 0.269 0.194 0.261 0.594
ρ 0.008 0.657 0.687 0.918 -0.958 0.394 0.647 0.390
n=800 β1 -0.021 0.139 0.144 0.930 0.208 0.105 0.176 0.468
β2 -0.017 0.202 0.210 0.952 0.269 0.152 0.230 0.484
ρ 0.081 0.542 0.565 0.936 -0.933 0.307 0.599 0.302
n=1000 β1 -0.003 0.120 0.123 0.946 0.226 0.095 0.140 0.404
β2 -0.017 0.177 0.179 0.962 0.284 0.135 0.190 0.462
ρ 0.036 0.465 0.483 0.936 -0.990 0.276 0.465 0.212
n=1500 β1 -0.002 0.097 0.097 0.954 0.218 0.078 0.127 0.310
β2 -0.012 0.143 0.138 0.962 0.271 0.112 0.165 0.368
ρ 0.012 0.372 0.372 0.948 -0.969 0.227 0.425 0.148
III: High Censored
n=200 β1 -0.288 0.376 1.293 0.866 -0.302 0.471 0.984 0.856
β2 -0.318 0.553 2.050 0.860 -0.447 0.726 1.388 0.950
ρ 1.954 1.859 10.658 0.676 2469 3.232 5.909 0.696
n=500 β1 -0.035 0.228 0.246 0.928 -0.069 0.253 0.314 0.780
β2 -0.021 0.333 0.325 0.932 -0.193 0.390 0.404 0.894
ρ 0.198 1.341 1.550 0.898 0.928 1.764 2.138 0.726
n=800 β1 -0.014 0.170 0.170 0.948 -0.018 0.177 0.251 0.756
β2 -0.024 0.250 0.260 0.936 -0.145 0.285 0.339 0.850
ρ 0.057 0.961 1.024 0.922 0.545 1.192 1.800 0.726
n=1000 β1 -0.020 0.153 0.152 0.948 -0.027 0.164 0.230 0.786
β2 -0.018 0.224 0.229 0.940 -0.145 0.264 0.320 0.836
ρ 0.083 0.870 0.941 0.938 0.554 1.113 1.648 0.744
n=1500 β1 -0.008 0.120 0.123 0.952 -0.007 0.146 0.206 0.788
β2 -0.023 0.177 0.173 0.950 -0.135 0.225 0.283 0.810
ρ 0.031 0.667 0.714 0.952 0.398 1.004 1.452 0.760
Since the existing approaches all estimate regression parameters by treating ρ as
known in the literature, and we implemented a simplified version of our approach
with known ρ for our simulated data. Table 4.7 provides the summarized results of
regression parameters estimation β in this case. As seen in Table 4.7, the estimation
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Table 4.6: Power Analysis of the proposed method for ρ = 1 (PO model). Note the
concave function is Λ0(t) = log(1 + t) + t1.5, convex function is Λ0(t) = 0.5t5/6 and
β = c(−1,−1). Sample size is 1500.
concave convex
ρ = 0.25 ρ = 0.5 ρ = 1 ρ = 2 ρ = 4 ρ = 0.25 ρ = 0.5 ρ = 1 ρ = 2 ρ = 4
I: Low Censored 1.000 0.986 0.046 0.926 0.994 1.000 0.968 0.058 0.884 0.960
II: Medium Censored 1.000 0.894 0.062 0.832 0.992 1.000 0.872 0.070 0.822 0.978
III: High Censored 0.780 0.392 0.050 0.274 0.828 0.686 0.324 0.068 0.174 0.798
Table 4.7: Summary Statistics of the proposed method with fixed parameter ρ, con-
cave function Λ0(t) = log(1 + t) + t1.5, convex function Λ0(t) = 0.5t5/6, β = c(−1,−1)
with 3 levels censoring rate (around 20% in I: Low Censored, 40% in II: Medium
Censored and 75% in III: High Censored), and sample size of 200.
concave convex
Par Bias StErr StDev CP Bias StErr StDev CP
I: Low Censored
ρ = 0.25 β1 -0.021 0.116 0.122 0.948 -0.017 0.114 0.117 0.948
β2 -0.024 0.200 0.209 0.946 -0.011 0.197 0.192 0.956
ρ = 0.5 β1 -0.007 0.126 0.126 0.948 -0.014 0.127 0.132 0.940
β2 0.004 0.222 0.223 0.952 -0.000 0.223 0.234 0.942
ρ = 1 β1 -0.020 0.146 0.148 0.944 -0.013 0.144 0.145 0.954
β2 -0.021 0.265 0.271 0.946 -0.025 0.261 0.277 0.930
ρ = 2 β1 -0.018 0.177 0.169 0.956 -0.019 0.178 0.182 0.956
β2 0.004 0.329 0.337 0.936 -0.032 0.330 0.308 0.956
ρ = 4 β1 -0.031 0.232 0.255 0.932 -0.023 0.233 0.248 0.928
β2 -0.034 0.420 0.416 0.944 -0.012 0.426 0.460 0.910
II: Medium Censored
ρ = 0.25 β1 -0.012 0.127 0.131 0.950 -0.018 0.127 0.128 0.954
β2 -0.008 0.222 0.232 0.934 -0.007 0.221 0.231 0.936
ρ = 0.5 β1 -0.027 0.140 0.143 0.944 -0.022 0.137 0.135 0.956
β2 0.006 0.246 0.237 0.960 -0.029 0.242 0.246 0.948
ρ = 1 β1 -0.017 0.156 0.154 0.966 -0.016 0.153 0.151 0.960
β2 -0.028 0.282 0.302 0.918 -0.006 0.275 0.259 0.970
ρ = 2 β1 -0.027 0.186 0.193 0.962 -0.013 0.184 0.181 0.958
β2 -0.005 0.343 0.358 0.932 0.000 0.337 0.345 0.942
ρ = 4 β1 -0.004 0.236 0.242 0.958 -0.023 0.236 0.248 0.932
β2 -0.055 0.442 0.448 0.948 -0.015 0.434 0.458 0.934
III: High Censored
ρ = 0.25 β1 -0.041 0.183 0.180 0.962 -0.029 0.184 0.192 0.952
β2 -0.033 0.326 0.343 0.942 -0.041 0.337 0.353 0.938
ρ = 0.5 β1 -0.039 0.197 0.202 0.944 -0.037 0.198 0.203 0.946
β2 -0.027 0.352 0.369 0.934 -0.029 0.360 0.369 0.932
ρ = 1 β1 -0.015 0.209 0.212 0.952 -0.038 0.215 0.227 0.926
β2 -0.014 0.380 0.385 0.942 -0.073 0.393 0.404 0.950
ρ = 2 β1 -0.041 0.238 0.246 0.956 -0.056 0.244 0.241 0.964
β2 -0.012 0.429 0.465 0.926 -0.067 0.441 0.426 0.934
ρ = 4 β1 -0.044 0.277 0.279 0.960 -0.036 0.274 0.284 0.944
β2 -0.018 0.498 0.523 0.918 -0.015 0.487 0.486 0.934
of the regression parameters is very good for all cases even when sample size is only
200.
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Figure 4.3: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with low censored rate (sample size 200).
Figure 4.4: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with low censored rate (sample size 500).
4.5 Real Data Analysis
The Surveillance, Epidemiology, and End Results (SEER) Program (Howlader et al.,
2019) is a source of epidemiologic information on the incidence and survival rates of
cancer in the United States, supported by the Surveillance Research Program (SRP)
in NCI’s Division of Cancer Control and Population Sciences (DCCPS). SEER col-
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Figure 4.5: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with low censored rate (sample size 1000).
Figure 4.6: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with low censored rate (sample size 1500).
lects and publishes cancer incidence and survival data from population-based cancer
registries covering approximately 34.6% of the population of the United States. The
SEER Program registries routinely collect data on patient demographics, primary
tumor site, tumor morphology and stage at diagnosis, first course of treatment, and
follow-up for vital status of dead or alive.
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Figure 4.7: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with medium censored rate (sample size 200).
Figure 4.8: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with medium censored rate (sample size 500).
Our data set comes from the SEER 1975-2016 Research Database (Howlader et
al., 2019). Specifically, we select a subset of the data for the Louisiana localized
lung cancer study. This data set contains subjects aged at least 50 from the state
of Louisiana whose diagnosis year is between 2004 to 2016. The response variable
of interest is the time to death since diagnosis, for which right-censored data are
available since not all patients died by 2016. Our data set only focuses on the data
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Figure 4.9: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with medium censored rate (sample size 1000).
Figure 4.10: Estimated baseline survival probability for the concave function Λ0(t) =
log(1 + t) + t1.5, β = c(−1,−1), ρ = 2 with medium censored rate (sample size 1500).
from white and black races although there are many other races in the original data
set. In total, there are 9,965 observations in this data set, and the right-censored
rate is 42.76%. We consider three covariates in this data analysis: “sex” taking 1
for female and 0 for male, “race” taking 1 for black race and 0 for white race, and
“grade”, which is a measurement of how closely the tumor cells resemble lung ranging
from 1 to 9 representing different degrees of differentiation.
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Table 4.9 presents the parameters estimation by the proposed approach under the
GOR model (Model I), the PH model (Model II) and the PO model (Model III).
The interior knots selected by the AIC and BIC are both 15 for the three models
shown in Table 4.8. Of the three models, Model I provides the smallest AIC of
29079.62. The regression estimators are (-0.244, 0.070, 0.135), which means that as
sex changes from male to female, the ratio of survival probability compared to the
placebo group would increase by exp (−0.244) = 0.783, and as race changes from
black to white, the ratio of survival probability increases by exp (0.070) = 1.073, and
the ratio of survival probability will rise by exp (0.135) = 1.145 as grade increases
by 1. The estimator of ρ is 1.493 in Model I, incidating the Model III has a slightly
higher AIC of 29083.56, and Model II provides the largest AIC of 29153.82. For
all these models, the estimated effects of sex and grade are significant with their
corresponding 95% confidence interval excluding 0, but race is not significant with
the 95% confidence interval containing 0. The estimator of the parameter ρ is 1.493
with the 95% confidence interval of (0.983, 2.003). Since this confidence interval
contains 1, it suggests that the PO model is also reasonable to fit this data, although
the GOR model with ρ = 1.493 is preferred. We also conducted the analysis with an
additional interaction term of sex and race in Table 4.10, which shows the interaction
term is not significant with the 95% confidence interval containing 0.
Table 4.8: SEER Louisiana Localized Lung Cancer Data: include sex, race and grade
in the survival function. Model I is to fit the data by estimating ρ with regression
parameters, Model II fixes ρ = 0, and Model III fits the data with fixed ρ = 1. The
best number of interior knots is searched for 10, 15, 20 and 25 based on AIC and
BIC.
10 15 20 25
Model I: proposed approach AIC 29136.66 29079.62 29122.66 29085.21
BIC 29259.17 29238.17 29317.24 29315.82
Model II: Fix ρ at 0 (PH Model) AIC 29205.09 29153.82 29194.27 29157.50
BIC 29320.40 29305.16 29381.65 29380.91
Model III: Fix ρ at 1 (PO Model) AIC 29138.65 29083.56 29125.74 29088.36
BIC 29253.96 29234.90 29313.12 29311.77
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Table 4.9: SEER Louisiana Localized Lung Cancer Data: parameters estimation in
the proposed EM algorithm, sex, race and grade are included in the survival function.
Interior knots are selected as 15 based on AIC and BIC for the three models.
Par Est StErr 95% CI
Model I: Proposed Approach β1 -0.244 0.045 (-0.332, -0.154)
β2 0.070 0.051 (-0.030, 0.170)
β3 0.135 0.010 (0.115, 0.154)
ρ 1.493 0.260 (0.983, 2.003)
AIC= 29079.62
Model II: Fix ρ at 0 (PH Model) β1 -0.155 0.027 (-0.209, -0.102)
β2 0.033 0.031 (-0.028, 0.094)
β3 0.077 0.004 (0.069, 0.084)
AIC= 29153.82
Model III: Fix ρ at 1 (PO Model) β1 -0.218 0.039 (-0.294, -0.142)
β2 0.056 0.045 (-0.032, 0.144)
β3 0.119 0.006 (0.108, 0.130)
AIC= 29083.56
Table 4.10: SEER Louisiana Localized Lung Cancer Data: parameters estimation in
the proposed EM algorithm, sex, race, grade and also the interaction of sex and race
are included in the survival function. Interior knots are selected as 15 based on AIC
and BIC for the three models.
Par Est StErr 95% CI
Model I: Proposed Approach β1 -0.261 0.051 (-0.362, -0.160)
β2 0.041 0.064 (-0.084, 0.166)
β12 0.080 0.105 (-0.126, 0.285)
β3 0.135 0.010 (0.115, 0.154)
ρ 1.495 0.260 (0.985, 2.006)
AIC=29081.04
Model II: Fix ρ at 0 (PH Model) β1 -0.166 0.031 (-0.226, -0.105)
β2 0.017 0.039 (-0.059, 0.093)
β12 0.046 0.065 (-0.081, 0.174)
β3 0.077 0.004 (0.069, 0.084)
AIC= 29155.31
Model III: Fix ρ at 1 (PO Model) β1 -0.233 0.044 (-0.319, -0.147)
β2 0.031 0.056 (-0.079, 0.141)
β12 0.069 0.093 (-0.113, 0.251)
β3 0.119 0.006 (0.108, 0.130)
AIC= 29085.00
Figure 4.11 and 4.12 show the predicted survival probability for different com-
bination of sex and race, and grade is set at the mean value of the data set. The
predicted survival probabilities are comparable to the Kaplan Meier curve. For both
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Figure 4.11: Predicted survival probability vs. Time (years) for White Female and
White Male in the SEER Localized Lung Cancer Data under the proposed method
and compared to the Kaplan Meier Curve. The proposed method predicts the survival
probability higher for white female than for white male.
the white and black people, female tends to have higher survival probability than
male, which is consistent with the estimation results in Table 4.9.
4.6 Discussions
In this paper, we investigate the identifiability issues of the GOR models and prove
that all the parameters including the parameter ρ are identifiable in regression set-
tings. However, estimating ρ in the GOR models can be problematic as reported
in many research articles. Our simulation results suggest that the estimation perfor-
mance of the propose approach is satisfactory if sample size is large enough. However,
the performance is heavily influenced by the right-censoring rate and the true value
of ρ. For example, when the true value of ρ is 0.25 and the right-censoring rate is
about 20%, the estimation of all parameters can be accurate if the sample size is 200;
however, when the true value of ρ is 4 with the same censoring rate, the sample size
needed for a satisfactory performance of the proposed method is about 2500.
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Figure 4.12: Predicted survival probability vs. Time (years) for Black Female and
Black Male in the SEER Localized Lung Cancer Data under the proposed method and
compared to the Kaplan Meier Curves. The proposed method predicts the survival
probability higher for black female than for black male.
The proposed approach based on the EM algorithm has several appealing prop-
erties such as being robust to initial values, easy to implement, fast to converge, and
providing variance estimates in closed form. Our approach allows to estimate the
regression parameters, the spline coefficients, and ρ jointly. Thus, it allows it allows
one to make inference on ρ and to conduct model comparison and testing in addition
to the estimation of the covariate effects and survival functions.
In terms of model selection, the proposed approach for the GOR models provides
more flexibility since it can estimate the parameter ρ with the regression parameters
simultaneously. AIC or BIC can be used to select the best model. In real life, however,
the PO model may have better interpretation and easy to understand in odds ratio
compared to the transformed odds ratio in the GOR models. If the confidence interval
of ρ estimator includes 1, then the PO model is suggested.
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Appendix A
The quantities involved in var(θ̂)
For notation simplicity, we use E(Y ) to denote the conditional expectation of a
quantity Y conditional on the observed data O, i.e., E(Y ) = E(Y |O,θ(d)). Similarly,
the covariances and variances below refer to the conditional covariances and variances
given the observed data O. In the Louis’s method, the first part of quantities are the
second derivative of Q(θ̂) with respective to θ,
∂2Q(θ,θ(d))
∂β∂β′
=
n∑
i=1
{−δiE(ψi)− E(φi)}
k∑
l=1
γlbl(yi) exp(xᵀiβ)xix′i
∂2Q(θ,θ(d))
∂γ2j
=
n∑
i=1
−γ−2j δiE(Zij)
∂2Q(θ,θ(d))
∂β∂γj
=
n∑
i=1
{−δiE(ψi)− E(φi)}bj(yi) exp(xᵀiβ)xi
∂2Q(θ,θ(d))
∂τ 2
=
n∑
i=1
{−δiτ−2 + τ−1 −
∂2lnΓ(τ)
∂τ 2
}.
Note that, ∂
2Q(θ,θ(d))
∂γj∂γj′
= 0 for j 6= j′, and also, ∂
2Q(θ,θ(d))
∂γj∂τ
= 0 and ∂
2Q(θ,θ(d))
∂β∂τ
= 0.
The second part of quantities in Louis’s method is the covariance of the first
derivative of logLc(θ) with respect of θ,
∂logLc(θ)
∂β
=
n∑
i=1
{δixi − δi
k∑
j=1
γjbj(yi) exp(xᵀiβ)ψixi −
k∑
j=1
γjbj(yi) exp(xᵀiβ)φixi}
∂logLc(θ)
∂γj
=
n∑
i=1
{δiZij
γj
− δibj(yi) exp(xᵀiβ)ψi − bj(yi) exp(x
ᵀ
iβ)φi}
∂logLc(θ)
∂τ
=
n∑
i=1
{−δiψi + δiτ−1 − φi + log(τ) + 1 + log(φi)−
Γ′(τ)
Γ(τ) }.
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Then
cov
(∂logLc(θ)
∂β
,
∂logLc(θ)
∂β
)
=
n∑
i=1
[
δi{
k∑
j=1
γjbj(yi)}2 exp(2xᵀiβ)var(ψi)xix′i
+ {
k∑
j=1
γjbj(yi)}2 exp(2xᵀiβ)var(φi)xix′i
]
cov
(∂logLc(θ)
∂γj
,
∂logLc(θ)
∂γj
)
=
n∑
i=1
{δivar(Zij)
γ2j
+ δib2j(yi) exp(2x
ᵀ
iβ)var(ψi)
+ b2j(yi) exp(2x
ᵀ
iβ)var(φi)
}
cov
(∂logLc(θ)
∂γj
,
∂logLc(θ)
∂γj′
)
=
n∑
i=1
{δicov(Zij, Zij′)
γjγj′
+ δibj(yi)bj′(yi) exp(2xᵀiβ)var(ψi)
+ bj(yi)bj′(yi) exp(2xᵀiβ)var(φi)
}
cov
(∂logLc(θ)
∂β
,
∂logLc(θ)
∂γj
)
=
n∑
i=1
{
δi
k∑
j=1
γjbj(yi) exp(2xᵀiβ)bj(yi)var(ψi)xi
+
k∑
j=1
γjbj(yi) exp(2xᵀiβ)bj(yi)var(φi)xi
}
cov
(∂logLc(θ)
∂τ
,
∂logLc(θ)
∂τ
)
=
n∑
i=1
{
δivar(ψi) + var(φi) + var(logφi)− 2cov(φi, logφi)
}
cov
(∂logLc(θ)
∂β
,
∂logLc(θ)
∂τ
)
=
n∑
i=1
{
δi
k∑
j=1
γjbj(yi) exp(xᵀiβ)var(ψi)xi
+
k∑
j=1
γjbj(yi) exp(xᵀiβ)var(φi)xi
−
k∑
j=1
γjbj(yi) exp(xᵀiβ)cov(φi, log(φi))xi
}
cov
(∂logLc(θ)
∂γj
,
∂logLc(θ)
∂τ
)
=
n∑
i=1
{
δibj(yi) exp(xᵀiβ)var(ψi) + bj(yi) exp(x
ᵀ
iβ)var(φi)
− bj(yi) exp(xᵀiβ)cov(φi, log(φi))
}
.
Note that cov(ψi, φi) = cov(Zij, ψi) = cov(Zij, φi) = cov(ψi, logφi) = 0, and
cov(φi, logφi) = E(φilogφi)− E(φi)E(logφi)
= Γ
′(τ + 1)
Γ(τ){Λ0(yi) exp(xᵀiβ) + τ}
− τ log{Λ0(yi) exp(x
ᵀ
iβ) + τ}
Λ0(yi) exp(xᵀiβ) + τ
− τΛ0(yi) exp(xᵀiβ) + τ
[Γ′(τ)
Γ(τ) − log{Λ0(yi) exp(x
ᵀ
iβ) + τ}
]
.
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The conditional covariance and variance terms have the following forms,
var(ψi|O;θ(d)) =
δi
{Λ(d)0 (yi) exp(xᵀiβ(d)) + τ (d)}2
var(φi|O;θ(d)) =
τ
{Λ(d)0 (yi)eβ
(d)Xi + τ (d)}2
var(Zij|O;θ(d)) =
γ
(d)
j Mj(yi)∑k
j=1 γ
(d)
j Mj(yi)
{1−
γ
(d)
j Mj(yi)∑k
j=1 γ
(d)
j Mj(yi)
}δi
cov(Zij, Zij′|O;θ(d)) = −
γ
(d)
j Mj(yi)∑k
j=1 γ
(d)
j Mj(yi)
γj′Mj′(yi)∑k
j=1 γ
(d)
j Mj(yi)
δi
var(log(φ)|O;θ(d)) = Γ
′′(τ)
Γ(τ) − {
Γ′(τ)
Γ(τ) }
2.
These closed-form expressions for variance estimation make computation more
efficient. The variance estimator for ρ is transformed via var(ρ) = τ−4var(τ).
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Appendix B
The EM algorithm for the PH model
For the PH model (ρ = 0), the observed likelihood function with observed data O
and parameters θ = (Λ0(·),β, τ) is
Lobs(θ; O) =
n∏
i=1
h(yi|xi)δiS(yi|xi)
=
n∏
i=1
{λ0(yi) exp(xᵀiβ)}δi exp{−Λ0(yi)}exp(x
ᵀ
i β),
and the log observed likelihood function is
`obs(θ; O) =
n∑
i=1
δilog{λ0(yi)}+ δixᵀiβ − Λ0(yi) exp(x
ᵀ
iβ).
The complete likelihood function with latent variable
Zi ∼ multinomial[1, ( 1k ,
1
k
, . . . , 1
k
)] for δi = 1 is
Lc(θ,θ(d); O) =
n∏
i=1
[ k∏
l=1
{γlMl(yi)}Zil exp(xᵀiβ)
]δi exp {−Λ0(yi)}exp(xᵀi β),
and then the expectation of logarithm complete likelihood function is expressed as
Q(θ,θ(d); O) =
n∑
i=1
δi
[ k∑
l=1
E(Zil|O;θ(d))log{γlMl(yi)}
]
+ δixᵀiβ − exp(x
ᵀ
iβ)
k∑
l=1
γlbl(yi).
(B.1)
By taking first partial derivative of equation (B.1) with γj and setting it to zero, the
updated quantity has closed form
γ∗j (β) =
∑n
i=1 δiE(Zij|O;θ(d))∑n
i=1 δi exp(x
ᵀ
iβ)bj(yi)
, j = 1, · · · , k. (B.2)
β is updated by solving ∑ni=1 δixi −∑kj=1 γ∗(d)j bj(yi) exp(xᵀiβ)xi = 0.
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For variance estimation via the Louis’s method, the quantities involved are
∂2Q(θ,θ(d))
∂β∂β′
=
n∑
i=1
− exp(xᵀiβ)xix′i
k∑
l=1
γlbl(yi)
∂2Q(θ,θ(d))
∂γ2j
=
n∑
i=1
−γ−2j δiE(Zij)
∂2Q(θ,θ(d))
∂β∂γj
=
n∑
i=1
−bj(yi) exp(xᵀiβ)xi
and
cov
(∂logLc(θ)
∂γj
,
∂logLc(θ)
∂γj
)
=
n∑
i=1
δ2i var(Zij)
γ2j
cov
(∂logLc(θ)
∂γj
,
∂logLc(θ)
∂γj′
)
=
n∑
i=1
δ2i cov(Zij, Zij′)
γjγj′
.
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